(Adopted at the 11th meeting of the 13th the NPC Standing Committee on June 29th, 2019)

Catalogue

　　Chapter I General Principles

　　Chapter II Vaccine Development and Registration

　　Chapter III Vaccine Production and Batch Issuance

　　Chapter IV Vaccine Circulation

　　Chapter V Vaccination

　　Chapter VI Monitoring and Handling of Abnormal Reaction

　　Chapter VII Post-marketing Management of Vaccines

　　Chapter VIII Safeguard Measures

　　Chapter IX Supervision and Administration

　　Chapter X Legal Liability

　　Chapter XI Supplementary Provisions

Chapter I General Principles

　　Article 1 This Law is formulated in order to strengthen vaccine management, ensure vaccine quality and supply, standardize vaccination, promote the development of vaccine industry, safeguard public health and safeguard public health safety.

　　Article 2 This Law shall apply to the development, production, circulation, vaccination and supervision and management of vaccines in People’s Republic of China (PRC). Where there are no provisions in this Law, the provisions of laws and administrative regulations such as the Drug Administration Law of People’s Republic of China (PRC) and the Law of People’s Republic of China (PRC) on the Prevention and Control of Infectious Diseases shall apply.

　　The term "vaccine" as mentioned in this Law refers to preventive biological products used for human immunization in order to prevent and control the occurrence and epidemic of diseases, including immunization planned vaccines and non-immunization planned vaccines.

　　Article 3 The state implements the strictest management system for vaccines, and adheres to safety first, risk management, whole-process control, scientific supervision and social co-governance.

　　Article 4 The State adheres to the strategic and public welfare nature of vaccine products.

　　The state supports basic and applied research on vaccines, promotes vaccine research and innovation, and incorporates vaccine research, production and storage for preventing and controlling major diseases into the national strategy.

　　The state formulates development plans and industrial policies for the vaccine industry, supports the development and structural optimization of the vaccine industry, encourages large-scale and intensive vaccine production, and continuously improves the vaccine production technology and quality level.

　　Article 5 The holder of a vaccine marketing license shall strengthen the quality management of the vaccine throughout its life cycle and be responsible for the safety, effectiveness and quality controllability of the vaccine.

　　Units and individuals engaged in vaccine development, production, circulation and vaccination activities shall abide by laws, regulations, rules, standards and norms, ensure that the information in the whole process is true, accurate, complete and traceable, assume responsibilities according to law and accept social supervision.

　　Article 6 The State implements an immunization planning system.

　　Residents living in China have the right to vaccinate the EPI according to law and fulfill the obligation to vaccinate the EPI. The government provides free immunization program vaccines to residents.

　　The people’s governments at or above the county level and their relevant departments shall ensure that school-age children are vaccinated with immunization programs. The guardian shall ensure that school-age children are vaccinated with EPI vaccine on time according to law.

　　Article 7 The people’s governments at or above the county level shall incorporate vaccine safety and vaccination into the national economic and social development plan at the corresponding level, strengthen the capacity building of vaccine supervision and management, and establish and improve the working mechanism of vaccine supervision and management.

　　The local people’s governments at or above the county level shall be responsible for the supervision and administration of vaccines in their respective administrative areas, and uniformly lead, organize and coordinate the supervision and administration of vaccines in their respective administrative areas.

　　Article 8 The drug supervision and administration department of the State Council is responsible for the supervision and administration of vaccines throughout the country. The competent department of health in the State Council is responsible for the supervision and management of national vaccination. Other relevant departments in the State Council are responsible for the supervision and management related to vaccines within their respective responsibilities.

　　The pharmaceutical supervisory and administrative departments of the people’s governments of provinces, autonomous regions and municipalities directly under the Central Government shall be responsible for the supervision and administration of vaccines in their respective administrative areas. The departments responsible for drug supervision and administration of the people’s governments at the municipal and county levels with districts (hereinafter referred to as the drug supervision and administration departments) shall be responsible for the supervision and administration of vaccines in their respective administrative areas. The competent health department of the local people’s government at or above the county level shall be responsible for the supervision and administration of vaccination in this administrative region. Other relevant departments of the local people’s governments at or above the county level shall be responsible for the supervision and administration of vaccines within their respective functions and duties.

　　Article 9 the State Council and the people’s governments of provinces, autonomous regions and municipalities directly under the Central Government shall establish departmental coordination mechanisms to coordinate the work related to vaccine supervision and management, regularly analyze the vaccine safety situation, strengthen vaccine supervision and management, and ensure vaccine supply.

　　Article 10 The State implements the whole-course electronic traceability system for vaccines.

　　The drug supervision and administration department of the State Council shall, jointly with the health authorities of the State Council, formulate unified standards and norms for vaccine traceability, establish a national collaborative platform for vaccine electronic traceability, and integrate the traceability information of the whole process of vaccine production, circulation and vaccination to realize vaccine traceability.

　　The holder of the vaccine marketing license shall establish a vaccine electronic traceability system, which is connected with the national vaccine electronic traceability collaborative platform, so as to realize the traceability and verifiability of the vaccine in the smallest packaging unit in the whole process of production, circulation and vaccination.

　　Disease prevention and control institutions and vaccination units shall truthfully record vaccine circulation and vaccination according to law, and provide traceability information to the national vaccine electronic traceability collaborative platform in accordance with regulations.

　　Article 11 In the process of vaccine development, production and inspection, we should establish and improve the biosafety management system, strictly control biosafety risks, strengthen biosafety management of pathogenic microorganisms such as bacterial strains, protect the health of operators and the public, and ensure that the use of pathogenic microorganisms such as bacterial strains is legal and legitimate.

　　The history, biological characteristics and generations of bacterial strains and cell strains used in vaccine development, production and inspection shall be clearly defined, and detailed files shall be established to ensure that the sources are legal, clear and traceable; Where the source is unknown, it shall not be used.

　　Article 12 People’s governments at all levels and their relevant departments, disease prevention and control institutions, vaccination units, vaccine marketing license holders and vaccine industry associations shall regularly carry out publicity, education and popularization of vaccine safety laws, regulations and vaccination knowledge through activities such as National Children’s Vaccination Day.

　　The news media should carry out public welfare publicity on vaccine safety laws, regulations and vaccination knowledge, and supervise vaccine violations by public opinion. Publicity and reporting on vaccines should be comprehensive, scientific, objective and fair.

　　Thirteenth vaccine industry associations should strengthen industry self-discipline, establish and improve industry norms, promote the construction of industry credit system, guide and urge members to carry out production and operation activities according to law.

Chapter II Vaccine Development and Registration

　　Article 14 The state shall, according to the epidemic situation of diseases, the immune status of the population and other factors, formulate relevant research and development plans, arrange necessary funds, and support the research and development of new vaccines such as multiple vaccines and multiple vaccines.

　　The state organizes vaccine marketing license holders, scientific research institutions and medical and health institutions to jointly tackle key problems and develop vaccines urgently needed for disease prevention and control.

　　Article 15 The State encourages vaccine marketing license holders to increase investment in research and innovation, optimize production technology, improve quality control level and promote vaccine technology progress.

　　Sixteenth to carry out clinical trials of vaccines shall be approved by the drug supervision and administration department of the State Council according to law.

　　Clinical trials of vaccines shall be carried out or organized by tertiary medical institutions or disease prevention and control institutions at or above the provincial level that meet the requirements set by the drug supervision and administration department of the State Council and the health authorities of the State Council.

　　The state encourages qualified medical institutions and disease prevention and control institutions to carry out clinical trials of vaccines according to law.

　　Article 17 An applicant for a vaccine clinical trial shall formulate a clinical trial plan, establish a clinical trial safety monitoring and evaluation system, carefully select the subjects, reasonably set the subjects’ groups and age groups, and take effective measures according to the degree of risk to protect the legitimate rights and interests of the subjects.

　　Eighteenth to carry out clinical trials of vaccines, the written informed consent of the subjects shall be obtained; If the subject is a person without civil capacity, he shall obtain the written informed consent of his guardian; If the subject is a person with limited capacity for civil conduct, he shall obtain the written informed consent of himself and his guardian.

　　Nineteenth vaccines listed in China shall be approved by the drug supervision and administration department of the State Council and obtain the drug registration certificate; To apply for vaccine registration, true, sufficient and reliable data, materials and samples shall be provided.

　　The State Council pharmaceutical supervisory and administrative department shall give priority to the review and approval of vaccines and innovative vaccines urgently needed for disease prevention and control.

　　Twentieth to deal with major public health emergencies in urgent need of vaccines or other vaccines identified by the health authorities in the State Council, the benefits outweigh the risks, the drug supervision and administration department of the State Council can conditionally approve the application for vaccine registration.

　　In case of particularly serious public health emergencies or other emergencies that seriously threaten public health, the health authorities in the State Council put forward suggestions for emergency use of vaccines according to the needs of prevention and control of infectious diseases, which can be used urgently within a certain scope and time limit with the consent of the drug supervision and administration department in the State Council.

　　Twenty-first the State Council pharmaceutical supervisory and administrative departments shall, when approving the application for vaccine registration, approve the production technology, quality control standards, instructions and labels of the vaccine.

　　The drug supervision and administration department of the State Council shall timely publish the contents of vaccine instructions and labels on its website.

Chapter III Vaccine Production and Batch Issuance

　　Article 22 The State implements a strict access system for vaccine production.

　　To engage in vaccine production activities, it shall be approved by the pharmaceutical supervisory and administrative department of the people’s government at or above the provincial level and obtain a pharmaceutical production license.

　　To engage in vaccine production activities, in addition to meeting the requirements of drug production activities stipulated in the Drug Administration Law of People’s Republic of China (PRC), the following conditions shall also be met:

　　(1) Having a moderate scale and sufficient production capacity reserve;

　　(2) Having systems, facilities and equipment to ensure biological safety;

　　(3) meeting the needs of disease prevention and control.

　　The holder of the vaccine marketing license shall have the vaccine production capacity; If it is really necessary to entrust production beyond the vaccine production capacity, it shall be approved by the drug supervision and administration department of the State Council. Those who accept commissioned production shall abide by the provisions of this law and the relevant provisions of the state to ensure the quality of vaccines.

　　Article 23 The legal representative and principal responsible person of the vaccine marketing license holder shall have a good credit record, and the personnel in key positions such as the person in charge of production management, the person in charge of quality management and the person authorized by quality shall have relevant professional background and working experience.

　　The holder of the vaccine marketing license shall strengthen the training and assessment of the personnel specified in the preceding paragraph, and report their positions and changes to the pharmaceutical supervisory and administrative departments of the people’s governments of provinces, autonomous regions and municipalities directly under the Central Government in a timely manner.

　　Article 24 Vaccines shall be produced and inspected according to the approved production technology and quality control standards, and the whole production process shall meet the requirements of good manufacturing practice.

　　The holder of the vaccine marketing license shall, in accordance with the provisions, review and inspect the whole process of vaccine production and vaccine quality.

　　Article 25 The holder of vaccine marketing license shall establish a complete production quality management system, continuously strengthen deviation management, and truthfully record all data formed in the production and inspection process by means of information technology to ensure that the whole production process continues to meet the statutory requirements.

　　Article 26 The State implements the system of batch issuance of vaccines.

　　Before each batch of vaccine is sold or imported, it shall be audited and tested by the batch issuing agency designated by the drug supervision and administration department of the State Council in accordance with the relevant technical requirements. If it meets the requirements, a batch issuance certificate will be issued; Do not meet the requirements, issued a notice of disapproval.

　　Vaccines that are not issued in batches shall not be sold, and shall be destroyed under the supervision of the pharmaceutical supervisory and administrative departments of the people’s governments of provinces, autonomous regions and municipalities directly under the Central Government; The imported vaccines that are not issued in batches shall be destroyed under the supervision of the drug supervision and administration department at the port location or otherwise handled according to law.

　　The State Council pharmaceutical supervisory and administrative departments and batch issuing institutions shall publish the batch issuing results of listed vaccines in time for public inquiry.

　　Article 27 To apply for batch issuance of vaccines, the batch issuing institution shall be provided with the batch production and inspection records, abstracts and other materials, and samples of products with the same batch number. Imported vaccines shall also provide certificates of origin and batch issuance; In case of exemption from batch issuance in the country of origin, a certificate of exemption from batch issuance shall be provided.

　　Twenty-eighth to prevent and control the epidemic situation of infectious diseases or to deal with emergencies, the vaccine is approved by the drug supervision and administration department of the State Council, and is exempted from batch issuance.

　　Twenty-ninth batches of vaccines should be issued batch by batch for data review and sampling inspection. The inspection items and inspection frequency of vaccine batch issuance shall be dynamically adjusted according to the risk assessment of vaccine quality.

　　If there are doubts about the authenticity of the application materials or samples for vaccine batch issuance, or there are other situations that need further verification, the batch issuing institution shall verify them, and if necessary, organize on-site verification by means of on-site sampling inspection.

　　Thirtieth batch issuing institutions found that there are significant quality risks in the process of batch issuance of vaccines, it shall promptly report to the pharmaceutical supervisory and administrative departments of the State Council and the people’s governments of provinces, autonomous regions and municipalities directly under the central government.

　　The department that receives the report shall immediately conduct on-site inspection on the vaccine marketing license holder, notify the batch issuing institution not to approve or suspend the batch issuance of the relevant products or all products of the vaccine marketing license holder according to the inspection results, and order the vaccine marketing license holder to rectify. The holder of the vaccine marketing license shall immediately rectify and report the rectification to the department that ordered it to rectify in time.

　　Article 31 The holder of the vaccine marketing license shall truthfully record the production process deviation, quality difference, faults and accidents in the production process and the measures taken, and specify them in the documents issued by the corresponding batch of products; If the quality of the vaccine may be affected, the holder of the vaccine marketing license shall take immediate measures and report to the pharmaceutical supervisory and administrative departments of the people’s governments of provinces, autonomous regions and municipalities directly under the Central Government.

Chapter IV Vaccine Circulation

　　Article 32 The national immunization program vaccine shall be subject to centralized bidding or unified negotiation by the competent health department of the State Council in conjunction with the financial department of the State Council, and the winning bid price or transaction price shall be formed and announced, and all provinces, autonomous regions and municipalities directly under the Central Government shall implement unified procurement.

　　Other EPI vaccines and non-EPI vaccines other than the national EPI vaccines are purchased by provinces, autonomous regions and municipalities directly under the Central Government through provincial public resource trading platforms.

　　Article 33 The price of vaccine shall be set by the holder of vaccine marketing license independently and reasonably according to law. The price level, price difference rate and profit rate of vaccines should be kept within a reasonable range.

　　Article 34 Provincial institutions for disease prevention and control shall, according to the national immunization program and the needs of disease prevention and control in their respective administrative areas, formulate plans for vaccine use in immunization programs in their respective administrative areas, and report to the departments that organize vaccine procurement in accordance with the relevant provisions of the state, and at the same time report to the health authorities of the people’s governments of provinces, autonomous regions and municipalities directly under the Central Government for the record.

　　Thirty-fifth vaccine marketing license holders should supply vaccines to disease prevention and control institutions in accordance with the procurement contract.

　　Disease prevention and control institutions shall supply vaccines to vaccination units in accordance with regulations.

　　Units and individuals other than disease prevention and control institutions shall not supply vaccines to vaccination units, and vaccination units shall not receive the vaccines.

　　Article 36 The holder of the vaccine marketing license shall distribute the vaccine to the disease prevention and control institution or the inoculation unit designated by the disease prevention and control institution in accordance with the purchase contract.

　　Vaccine marketing license holders and disease prevention and control institutions shall have the conditions for cold chain storage and transportation of vaccines, and may also entrust qualified vaccine distribution units to distribute vaccines.

　　Disease prevention and control institutions can charge storage and transportation fees for the distribution of non-immunization-planned vaccines. The specific measures shall be formulated by the financial department of the State Council in conjunction with the competent price department of the State Council, and the charging standards shall be formulated by the competent price department of the people’s governments of provinces, autonomous regions and municipalities directly under the Central Government in conjunction with the financial department.

　　Thirty-seventh disease prevention and control institutions, vaccination units, vaccine marketing license holders and vaccine distribution units shall abide by the management norms of vaccine storage and transportation to ensure the quality of vaccines.

　　Vaccines should be in the specified temperature environment during the whole process of storage and transportation, and the cold chain storage and transportation should meet the requirements, and the temperature should be monitored and recorded regularly.

　　The management standards for vaccine storage and transportation are jointly formulated by the drug supervision and administration department of the State Council and the health department of the State Council.

　　Article 38 When selling vaccines, the holder of the vaccine marketing license shall provide a copy of the batch issuance certificate or an electronic document stamped with his seal; Sales of imported vaccines, should also provide a copy of the customs clearance form for imported drugs or electronic documents stamped with its seal.

　　Disease prevention and control institutions and vaccination units shall, when receiving or purchasing vaccines, obtain the supporting documents specified in the preceding paragraph and keep them for future reference for not less than five years after the expiration of the vaccine.

　　Article 39 The holder of the vaccine marketing license shall, in accordance with the regulations, establish a true, accurate and complete sales record and keep it for future reference for not less than five years after the expiration of the vaccine.

　　Disease prevention and control institutions, vaccination units and vaccine distribution units shall, in accordance with regulations, establish true, accurate and complete records of receipt, purchase, storage, distribution and supply, and keep them for future reference for not less than five years after the expiration of the vaccine.

　　When the disease prevention and control institutions and inoculation units receive or purchase vaccines, they shall obtain the temperature monitoring records of the whole process of transportation and storage, and keep them for future reference for not less than five years after the expiration of the vaccine; If the temperature monitoring records of the whole transportation and storage process cannot be provided or the temperature control does not meet the requirements, it shall not be accepted or purchased, and it shall immediately report to the pharmaceutical supervisory and administrative department and the health department of the local people’s government at or above the county level.

　　Article 40 Disease prevention and control institutions and inoculation entities shall establish a system of regular inspection of vaccines, and take measures such as isolated storage and setting warning signs for vaccines with unrecognizable packaging, unqualified storage temperature, and expiration date, and dispose of them in accordance with the provisions of the State Council drug supervision and administration department, health department and ecological environment department. Disease prevention and control institutions and vaccination units shall truthfully record the disposal situation, and the disposal records shall be kept for future reference for not less than five years after the expiration of the vaccine.

Chapter V Vaccination

　　Forty-first the State Council health authorities to develop a national immunization program; The types of vaccines under the National Immunization Program shall be drawn up by the competent health department of the State Council in conjunction with the financial department of the State Council, and published after being approved by the State Council.

　　The competent department of health in the State Council established the national immunization program expert advisory committee, and established the dynamic adjustment mechanism of vaccine types in the national immunization program together with the financial department of the State Council.

　　The people’s governments of provinces, autonomous regions and municipalities directly under the Central Government may, when implementing the national immunization program, increase the types of vaccines for immunization programs according to the needs of disease prevention and control in their respective administrative areas, and report them to the health authorities in the State Council for the record and publication.

　　Forty-second the State Council health authorities should formulate and publish vaccination work norms, and strengthen the standardized management of vaccination.

　　The competent department of health in the State Council shall formulate and publish the immunization procedures of the national immunization program vaccine and the guiding principles for the use of the non-immunization program vaccine.

　　The competent health authorities of the people’s governments of provinces, autonomous regions and municipalities directly under the Central Government shall formulate vaccination plans in light of the actual conditions of their respective administrative regions and report them to the competent health authorities of the State Council for the record.

　　Forty-third disease prevention and control institutions at all levels shall, according to their respective responsibilities, carry out publicity, training, technical guidance, monitoring, evaluation, epidemiological investigation and emergency response related to vaccination.

　　Article 44 An inoculation entity shall meet the following conditions:

　　(1) Obtaining the practice license of a medical institution;

　　(2) Having doctors, nurses or rural doctors who have received professional vaccination training organized by the health authorities of the people’s government at the county level and passed the examination;

　　(3) Having cold storage facilities, equipment and a cold storage system that meet the management standards for vaccine storage and transportation.

　　The competent health department of the local people’s government at or above the county level shall designate qualified medical institutions to undertake the immunization program vaccination work in the responsible area. Eligible medical institutions can undertake non-immunization vaccination work, and shall report to the competent health department that issued the practice license of their medical institutions for the record.

　　Vaccination units should strengthen internal management, and carry out vaccination work should abide by vaccination work norms, immunization procedures, vaccine use guidelines and vaccination programs.

　　Disease prevention and control institutions at all levels shall strengthen the technical guidance on vaccination work of vaccination units and the management of vaccine use.

　　Article 45 When carrying out vaccination, medical and health personnel shall inform the recipients or their guardians of the varieties, functions, contraindications, adverse reactions, on-site observation and other matters needing attention, inquire about the health status of the recipients and whether there are any contraindications to vaccination, and record the information truthfully. The recipient or his guardian shall truthfully provide the health status and vaccination contraindications of the recipient. If vaccination is forbidden, medical and health personnel shall give medical advice to the recipient or his guardian, and truthfully record the medical advice.

　　Before vaccination, medical and health personnel should check the health status of the recipients, check the vaccination contraindications, check the vaccination certificate, check the appearance, batch number and expiration date of the vaccine and syringe, check the name and age of the recipients and the name, specification, dosage, vaccination site and vaccination route of the vaccine, and ensure that the recipients, vaccination certificate and vaccine information are consistent before vaccination can be implemented.

　　Medical and health personnel shall vaccinate the recipients who meet the vaccination conditions. In case of adverse reactions of the seed recipients during the on-site observation, medical and health personnel shall take timely treatment and other measures in accordance with the requirements of vaccination work norms.

　　Article 46 Medical and health personnel shall truthfully, accurately and completely record the vaccination information such as the vaccine variety, the identification information of the marketing license holder, the smallest packaging unit, the expiration date, the vaccination time, the medical and health personnel who carried out the vaccination, the recipients, etc. in accordance with the regulations of the health authorities in the State Council, so as to ensure that the vaccination information can be traced and inquired. Vaccination records shall be kept for no less than five years after the expiration of the vaccine.

　　Article 47 The state practices a vaccination certificate system for children. Within one month after a child is born, his guardian shall apply for a vaccination certificate at the vaccination unit or the birth hospital where the child lives. The vaccination unit or the hospital of birth shall not refuse to handle it. The guardian shall properly keep the vaccination certificate.

　　Vaccination shall be administered by the place of residence. During the period when children leave their original place of residence, the vaccination unit undertaking vaccination at the current place of residence shall be responsible for vaccination.

　　The format of vaccination certificate shall be stipulated by the competent health department of the State Council.

　　Article 48 When children enter kindergartens and schools, nursery institutions and schools should check their vaccination certificates. If they find that they have not been vaccinated in accordance with the regulations, they should report to the vaccination unit where the children live or where the nursery institutions and schools are located, and cooperate with the vaccination unit to urge their guardians to replant in accordance with the regulations. Disease prevention and control institutions shall provide technical guidance for kindergartens and schools to check vaccination certificates.

　　Measures for the inspection of children’s nursery and school vaccination certificates shall be formulated by the competent department of health of the State Council in conjunction with the administrative department of education of the State Council.

　　Forty-ninth vaccination units shall not charge any fees for vaccination.

　　Inoculation units can charge vaccination service fees in addition to vaccine fees for non-immunization programs. The charging standards for vaccination service fees shall be formulated by the competent price departments of the people’s governments of provinces, autonomous regions and municipalities directly under the Central Government in conjunction with the financial departments.

　　Article 50 The competent health department of the local people’s government at or above the county level may, according to the information of infectious disease monitoring and early warning, report to the people’s government at the corresponding level for decision and report to the competent health department of the people’s government at or above the provincial level for the record, and carry out mass vaccination in the administrative area.

　　If it is necessary to carry out mass vaccination nationwide or across provinces, autonomous regions and municipalities directly under the Central Government, it shall be decided by the health authorities in the State Council.

　　The local people’s government at or above the county level or the competent department of health in the State Council, which has made the decision on mass vaccination, shall organize the relevant departments to do a good job in personnel training, publicity and education, and material mobilization.

　　No unit or individual may carry out mass vaccination without authorization.

　　Article 51 If the local people’s governments at or above the county level or their health authorities need to take emergency vaccination measures during the outbreak and epidemic of infectious diseases, it shall be implemented in accordance with the provisions of laws and administrative regulations.

Chapter VI Monitoring and Handling of Abnormal Reaction

　　Article 52 The term "abnormal reaction to vaccination" refers to the adverse drug reaction that a qualified vaccine causes damage to the tissues, organs and functions of the recipient during or after the implementation of standardized vaccination, and all parties concerned are not at fault.

　　The following situations do not belong to the abnormal reaction of vaccination:

　　(a) the general reaction after vaccination caused by the characteristics of the vaccine itself;

　　(2) Damage caused to the recipients due to vaccine quality problems;

　　(three) the damage caused to the recipients by the vaccination unit’s violation of the vaccination work norms, immunization procedures, guiding principles for vaccine use, and vaccination programs;

　　(four) the recipient is in the incubation period or precursor period of a disease at the time of inoculation, and the disease is coupled after inoculation;

　　(5) The recipient has vaccination contraindications specified in the vaccine instructions, and the recipient or his guardian failed to truthfully provide the health status and vaccination contraindications of the recipient before vaccination, and the original disease of the recipient has an acute recurrence or aggravation after vaccination;

　　(6) Psychogenic reactions of individuals or groups due to psychological factors.

　　Article 53 The State shall strengthen the monitoring of abnormal reactions to vaccination. The monitoring plan for abnormal reaction of vaccination shall be formulated by the competent health department of the State Council in conjunction with the drug supervision and administration department of the State Council.

　　Fifty-fourth vaccination units, medical institutions and other suspected abnormal reactions to vaccination shall report to the disease prevention and control institutions in accordance with regulations.

　　The holder of the vaccine marketing license shall set up a special institution with full-time staff to actively collect, track and analyze the suspected abnormal vaccination reactions, take timely risk control measures, report the suspected abnormal vaccination reactions to the disease prevention and control institutions, and submit the quality analysis report to the pharmaceutical supervisory and administrative departments of the people’s governments of provinces, autonomous regions and municipalities directly under the Central Government.

　　Article 55 In case of suspected abnormal reaction to vaccination, the disease prevention and control institutions shall report it in time according to the regulations, organize investigation and diagnosis, and inform the recipients or their guardians of the conclusions of the investigation and diagnosis. If the conclusion of the investigation and diagnosis is controversial, you can apply for appraisal according to the appraisal method formulated by the competent department of health in the State Council.

　　Due to vaccination, the recipient dies, is severely disabled, or has a significant impact on the society, such as group suspected vaccination abnormal reaction. The competent health department and drug supervision and administration department of the people’s government at or above the municipal level with districts shall, according to their respective functions and duties, organize investigation and handling.

　　Article 56 The state practices a compensation system for abnormal reactions to vaccination. In the process of vaccination or after vaccination, the recipient’s death, serious disability, organ and tissue damage and other damages are abnormal reactions to vaccination or cannot be ruled out, and compensation should be given. The scope of compensation shall be managed by catalogue and dynamically adjusted according to the actual situation.

　　The compensation expenses required for immunization planning vaccine shall be arranged by the financial departments of the people’s governments of provinces, autonomous regions and municipalities directly under the Central Government in the vaccination funds; The compensation expenses required for vaccination of non-EPI vaccines shall be borne by the holders of relevant vaccine marketing licenses. The state encourages people who have received abnormal vaccination to be compensated through commercial insurance and other forms.

　　Compensation for abnormal reaction of vaccination should be timely, convenient and reasonable. The scope, standards and procedures of compensation for abnormal reaction of vaccination shall be stipulated by the State Council, and the provinces, autonomous regions and municipalities directly under the Central Government shall formulate specific implementation measures.

Chapter VII Post-marketing Management of Vaccines

　　Article 57 The holder of the vaccine marketing license shall establish and improve the quality management system of the whole life cycle of the vaccine, formulate and implement the post-marketing risk management plan of the vaccine, conduct post-marketing research of the vaccine, and further confirm the safety, effectiveness and quality controllability of the vaccine.

　　For vaccines that require further research when approving the application for vaccine registration, the vaccine marketing license holder shall complete the research within the prescribed time limit; If the research is not completed within the time limit or it cannot be proved that the benefits outweigh the risks, the drug supervision and administration department of the State Council shall handle it according to law until the drug registration certificate of the vaccine is cancelled.

　　Fifty-eighth vaccine marketing license holders should carry out quality tracking analysis of vaccines, continuously improve quality control standards, improve production processes, and improve the stability of production processes.

　　If the production process, production site and key equipment are changed, it shall be evaluated and verified, and filed or reported in accordance with the provisions of the drug supervision and administration department of the State Council on change management; Changes that may affect the safety, effectiveness and quality controllability of vaccines shall be approved by the drug supervision and administration department of the State Council.

　　Article 59 The holder of a vaccine marketing license shall continuously update the instructions and labels according to the post-marketing research and abnormal reaction of vaccination, and apply for approval or filing in accordance with regulations.

　　The State Council drug supervision and administration department shall publish the updated vaccine instructions and labels on its website in time.

　　Article 60 The holder of a vaccine marketing license shall establish a system of retrospective analysis and risk reporting of vaccine quality, and truthfully report the production and circulation of vaccine, post-marketing research and risk management to the drug supervision and administration department of the State Council every year according to regulations.

　　Article 61 The drug supervision and administration department of the State Council may, according to the actual situation, order the holder of vaccine marketing license to carry out post-marketing evaluation or directly organize post-marketing evaluation.

　　The drug supervision and administration department of the State Council shall cancel the drug registration certificate of the vaccine that has a serious abnormal reaction to vaccination or is harmful to human health for other reasons.

　　Article 62 The pharmaceutical supervisory and administrative department of the State Council may, according to the needs of disease prevention and control and the development of vaccine industry, organize post-marketing evaluation of vaccine varieties. If it is found that the product design, production process, safety, effectiveness or quality controllability of this vaccine variety are obviously inferior to other vaccine varieties for preventing and controlling the same disease, it shall cancel the drug registration certificates of all vaccines of this variety and abolish the corresponding national drug standards.

Chapter VIII Safeguard Measures

　　Sixty-third people’s governments at or above the county level shall include the funds needed for vaccine safety, purchase of planned vaccines for immunization, vaccination and information construction in the government budget at the corresponding level to ensure the implementation of the immunization planning system.

　　The people’s government at the county level shall, in accordance with the relevant provisions of the state, grant subsidies to rural doctors and other primary medical and health personnel engaged in vaccination work.

　　The state supports vaccination work in economically underdeveloped areas according to needs. The people’s governments of provinces, autonomous regions and municipalities directly under the Central Government and the people’s governments at the municipal level divided into districts shall give necessary financial subsidies to the people’s governments at the county level in economically underdeveloped areas to carry out the work related to vaccination.

　　Article 64 The people’s governments of provinces, autonomous regions and municipalities directly under the Central Government shall, according to the epidemic trend of infectious diseases in their respective administrative areas, determine the projects related to vaccination within the scope of infectious disease prevention and control projects determined by the health authorities in the State Council, and ensure the implementation of the projects.

　　Article 65 The competent health authorities of the State Council shall provide the vaccine marketing license holders with information on the vaccine demand of the national immunization program according to the vaccine use plans of the national immunization programs of all provinces, autonomous regions and municipalities directly under the Central Government, and the vaccine marketing license holders shall make reasonable arrangements for production according to the vaccine demand information.

　　When there is a risk of vaccine supply shortage, the health authorities in the State Council and the drug supervision and administration departments in the State Council put forward suggestions, and the departments in charge of industry and information technology in the State Council and the finance department in the State Council should take effective measures to ensure vaccine production and supply.

　　The holder of vaccine marketing license shall organize production according to law to ensure vaccine supply; If the holder of the vaccine marketing license stops vaccine production, it shall report to the drug supervision and administration department of the State Council or the drug supervision and administration department of the people’s government of a province, autonomous region or municipality directly under the Central Government in time.

　　Article 66 The State shall include vaccines in the strategic material reserve, and implement the reserve at the central and provincial levels.

　　The competent department of industry and information technology in the State Council and the financial department shall, jointly with the health authorities, public security departments, market supervision and management departments and drug supervision and management departments in the State Council, strengthen the production capacity and product management of vaccine reserves and establish a dynamic adjustment mechanism according to the needs of disease prevention, control and public health emergency preparedness.

　　Sixty-seventh financial arrangements at all levels for vaccination funds should be earmarked, and no unit or individual may misappropriate or occupy them.

　　The relevant units and individuals shall accept the audit supervision of audit institutions in accordance with the law when using the funds for vaccination.

　　Article 68 The State implements a compulsory vaccine liability insurance system.

　　The holder of the vaccine marketing license shall take out compulsory vaccine liability insurance in accordance with the regulations. If the vaccine quality problem causes damage to the recipient, the insurance company shall pay compensation within the insured liability limit.

　　The specific measures for the implementation of the compulsory vaccine liability insurance system shall be formulated by the drug supervision and administration department of the State Council in conjunction with the health authorities of the State Council and the insurance supervision and administration institutions.

　　Article 69 When an infectious disease breaks out and is prevalent, the holder of the relevant vaccine marketing license shall timely produce and supply vaccines for preventing and controlling infectious diseases. Transportation units should give priority to the transportation of vaccines for the prevention and control of infectious diseases. The people’s governments at or above the county level and their relevant departments shall do a good job in organization, coordination and guarantee.

Chapter IX Supervision and Administration

　　Article 70 The drug supervision and administration department and the competent health department shall, according to their respective functions and duties, supervise and manage the whole process of vaccine development, production, circulation and vaccination, and supervise the holders of vaccine marketing license, disease prevention and control institutions and vaccination units to perform their obligations according to law.

　　The pharmaceutical supervisory and administrative departments shall supervise and inspect the quality of vaccines in vaccine development, production, storage, transportation and vaccination according to law. Health authorities shall supervise and inspect the implementation of immunization planning system and vaccination activities according to law.

　　The drug supervision and administration department shall strengthen the on-site inspection of vaccine marketing license holders; When necessary, units and individuals that provide products or services for vaccine development, production, circulation and other activities may be subject to extended inspection; The relevant units and individuals shall cooperate and shall not refuse or conceal.

　　Article 71 The state builds a team of professional and specialized drug inspectors at the central and provincial levels, and strengthens the supervision and inspection of vaccines.

　　The pharmaceutical supervisory and administrative departments of the people’s governments of provinces, autonomous regions and municipalities directly under the Central Government shall send inspectors to the holders of vaccine marketing licenses. Inspectors are responsible for supervising and inspecting the implementation of good manufacturing practice, collecting clues about vaccine quality risks and violations of laws and regulations, reporting the situation to the pharmaceutical supervisory and administrative departments of the people’s governments of provinces, autonomous regions and municipalities directly under the Central Government and making suggestions, and being responsible for the behavior during their stationing.

　　Article 72 If there are potential safety hazards in vaccine quality management, and the holder of vaccine marketing license fails to take timely measures to eliminate them, the pharmaceutical supervisory and administrative department may take measures such as responsibility interview and rectification within a time limit.

　　Serious violation of drug-related quality management norms, the drug supervision and administration department shall order the suspension of vaccine production, sales and distribution, and immediately rectify; After the rectification is completed, production, sales and distribution can only be resumed if the drug supervision and administration department checks that it meets the requirements.

　　The drug supervision and administration department shall establish a credit record system for vaccine marketing license holders and their related personnel, incorporate it into the national credit information sharing platform, publicize their serious dishonesty information in accordance with the regulations, and implement joint punishment.

　　Article 73 If there are or are suspected to be quality problems with vaccines, the vaccine marketing license holders, disease prevention and control institutions and inoculation entities shall immediately stop selling, distributing and using, and stop production if necessary, and report to the pharmaceutical supervisory and administrative departments and health authorities of the people’s governments at or above the county level in accordance with regulations. The competent health department shall immediately organize disease prevention and control institutions and inoculation units to take necessary emergency measures and report to the competent health department of the people’s government at a higher level. The pharmaceutical supervisory and administrative department shall take measures such as sealing up and detaining according to law. For vaccines that have been sold, the holder of the vaccine marketing license shall promptly notify the relevant disease prevention and control institutions, vaccine distribution units and inoculation units, recall them in accordance with regulations, and truthfully record the recall and notification, and the disease prevention and control institutions, vaccine distribution units and inoculation units shall cooperate.

　　If the production, sale, distribution, use or recall of vaccines are not stopped in accordance with the provisions of the preceding paragraph, the pharmaceutical supervisory and administrative departments and health authorities of the people’s governments at or above the county level shall, according to their respective functions and duties, order them to stop production, sale, distribution, use or recall of vaccines.

　　Vaccine marketing license holders, disease prevention and control institutions, and vaccination units shall not conceal, falsely report, delay reporting or omit reporting vaccines that have or are suspected to have quality problems, and shall not conceal, forge or destroy relevant evidence.

　　Article 74 The holder of a vaccine marketing license shall establish an information disclosure system, and timely disclose information such as vaccine product information, instructions and labels, implementation of relevant quality management standards for drugs, batch issuance, recall, acceptance of inspection and punishment, and compulsory insurance for vaccine liability on its website in accordance with regulations.

　　Article 75 The drug supervision and administration department of the State Council shall establish an information sharing mechanism on vaccine quality and vaccination together with the health authorities of the State Council.

　　The pharmaceutical supervisory and administrative departments and health authorities of the people’s governments at or above the provincial level shall organize vaccine marketing license holders, disease prevention and control institutions, vaccination units, news media, scientific research units, etc. to exchange information on vaccine quality and vaccination in accordance with the principles of science, objectivity, timeliness and openness.

　　Article 76 The State implements a unified system for publishing vaccine safety information.

　　Vaccine safety risk warning information, major vaccine safety accidents and their investigation and handling information, and other vaccine safety information determined by the State Council that needs to be published uniformly shall be published by the drug supervision and administration department of the State Council jointly with relevant departments. The national report on the abnormal reaction to vaccination shall be uniformly published by the competent health department of the State Council in conjunction with the drug supervision and administration department of the State Council. The above information shall not be released without authorization. The release of major vaccine safety information should be timely, accurate and comprehensive, and scientific evaluation should be made in accordance with the provisions, and necessary explanations should be made.

　　The pharmaceutical supervisory and administrative department of the people’s government at or above the county level shall immediately verify and analyze the vaccine safety information that may mislead the public and public opinion, in conjunction with the health authorities and other relevant departments, professional institutions and relevant vaccine marketing license holders, and publish the results in a timely manner.

　　No unit or individual may fabricate or disseminate false vaccine safety information.

　　Article 77 Any unit or individual has the right to know vaccine information according to law and put forward opinions and suggestions on vaccine supervision and management.

　　Any unit or individual has the right to report vaccine violations to the health authorities, drug supervision and administration departments and other departments, and to report to the people’s government at the same level or higher level and its relevant departments and supervisory organs if the health authorities, drug supervision and administration departments and their staff fail to perform their supervisory and administrative duties according to law. The relevant departments and organs shall promptly verify and deal with it; Reward informants for verified reports in accordance with regulations; Informants who report serious illegal acts of their units and verify them are rewarded handsomely.

　　Article 78 The people’s governments at or above the county level shall formulate emergency plans for vaccine safety incidents, and stipulate the classification of vaccine safety incidents, the organization and command system and responsibilities for handling, the prevention and early warning mechanism, the handling procedures and emergency safeguard measures.

　　The holder of the vaccine marketing license shall formulate a plan for handling vaccine safety incidents, regularly check the implementation of various preventive measures, and eliminate potential safety hazards in time.

　　In the event of a vaccine safety incident, the holder of the vaccine marketing license shall immediately report to the drug supervision and administration department of the State Council or the drug supervision and administration department of the people’s government of a province, autonomous region or municipality directly under the Central Government; Disease prevention and control institutions, vaccination units and medical institutions shall immediately report to the health authorities and drug supervision and administration departments of the people’s governments at or above the county level. The pharmaceutical supervisory and administrative department shall, jointly with the health authorities, set up a command organization for handling vaccine safety incidents in accordance with the provisions of the emergency plan, carry out medical treatment, risk control, investigation and handling, information release, explanation and other work, and do a good job in the aftermath of replanting. The cost of replanting vaccine safety incidents caused by quality problems shall be borne by the holder of vaccine marketing license.

　　The relevant units and individuals shall not conceal, falsely report, delay reporting or omit reporting vaccine safety incidents, and shall not conceal, forge or destroy relevant evidence.

Chapter X Legal Liability

　　Article 79 Whoever violates the provisions of this Law and constitutes a crime shall be severely investigated for criminal responsibility according to law.

　　Article 80 If the vaccines produced and sold belong to counterfeit drugs, the pharmaceutical supervisory and administrative department of the people’s government at or above the provincial level shall confiscate the illegal income, vaccines produced and sold illegally, raw materials, auxiliary materials, packaging materials, equipment and other articles specially used for illegal vaccine production, order it to stop production and business for rectification, revoke the pharmaceutical registration certificate until the pharmaceutical production license is revoked, and impose a fine of not less than 15 times but not more than 50 times the value of vaccines produced and sold illegally. If the value of vaccines is less than 500,000 yuan, it shall be calculated as 500,000 yuan.

　　If the vaccines produced and sold are inferior drugs, the pharmaceutical supervisory and administrative department of the people’s government at or above the provincial level shall confiscate the illegal income and vaccines produced and sold illegally, as well as raw materials, auxiliary materials, packaging materials, equipment and other items specially used for illegal vaccine production, order it to stop production and business for rectification, and impose a fine of not less than 10 times but not more than 30 times the value of vaccines produced and sold illegally. If the value is less than 500,000 yuan, it shall be calculated as 500,000 yuan. If the circumstances are serious, the drug registration certificate shall be revoked until the drug production license is revoked.

　　If the vaccines produced and sold are fake drugs, or the vaccines produced and sold are inferior drugs and the circumstances are serious, the pharmaceutical supervisory and administrative department of the people’s government at or above the provincial level shall confiscate the income earned by the unit during the illegal act, impose a fine of more than one time and less than ten times the income earned, prohibit the pharmaceutical production and business activities for life, and be detained by the public security organ for more than five days and less than fifteen days.

　　Article 81 Under any of the following circumstances, the pharmaceutical supervisory and administrative department of the people’s government at or above the provincial level shall confiscate the illegal income and vaccines illegally produced and sold, as well as raw materials, auxiliary materials, packaging materials, equipment and other articles specially used for illegal vaccine production, order it to stop production and business for rectification, and impose a fine of not less than 15 times but not more than 50 times the value of illegally produced and sold vaccines. If the value is less than 500,000 yuan, it shall be calculated as 500,000 yuan; If the circumstances are serious, the relevant drug approval documents shall be revoked until the drug production license is revoked. The legal representative, principal responsible person, directly responsible person in charge, key position personnel and other responsible personnel shall be confiscated, and they shall be fined more than 50% but less than 10 times of the income earned. They shall be prohibited from engaging in drug production and business activities for ten years until life, and shall be detained by public security organs for more than five days and less than fifteen days:

　　(1) Providing false data, materials, samples or committing other deceptive acts when applying for clinical trials, registration and batch issuance of vaccines;

　　(two) fabricating production and inspection records or changing the batch number of products;

　　(3) Units or individuals other than disease prevention and control institutions supply vaccines to vaccination units;

　　(four) commissioned the production of vaccines without approval;

　　(five) the production process, production site, key equipment and other changes in accordance with the provisions should be approved without approval;

　　(6) Updating vaccine instructions and labels shall be approved without approval according to regulations.

　　Article 82 Unless otherwise provided for in this Law, if the holder of vaccine marketing license or any other unit violates the relevant quality control standards of drugs, the pharmaceutical supervisory and administrative department of the people’s government at or above the county level shall order it to make corrections and give it a warning; Refuses to correct, a fine of two hundred thousand yuan and five hundred thousand yuan; If the circumstances are serious, a fine of not less than 500,000 yuan but not more than 3 million yuan shall be imposed, and the company shall be ordered to suspend production and business for rectification until the relevant drug approval documents and drug production licenses are revoked. The legal representative, principal responsible person, directly responsible person in charge, personnel in key positions and other responsible personnel shall be confiscated from their own units during the illegal act, and a fine of not less than 50% but not more than 5 times shall be imposed, and they shall be prohibited from engaging in drug production and business activities for ten years until life.

　　Article 83 If a holder of a vaccine marketing license violates the provisions of this Law in any of the following circumstances, the pharmaceutical supervisory and administrative department of the people’s government at or above the provincial level shall order him to make corrections and give him a warning; Refuses to correct, a fine of two hundred thousand yuan and five hundred thousand yuan; If the circumstances are serious, it shall be ordered to suspend production and business for rectification, and a fine of not less than 500,000 yuan but not more than 2 million yuan shall be imposed:

　　(1) Failing to establish an electronic traceability system for vaccines as required;

　　(two) the legal representative, the main person in charge, the person in charge of production management, the person in charge of quality management, the quality authorized person and other key positions do not meet the prescribed conditions or fail to carry out training and assessment in accordance with the provisions;

　　(3) Failing to report or put on record as required;

　　(4) Failing to carry out post-marketing research in accordance with the regulations, or failing to set up institutions and staff in accordance with the regulations to actively collect, track and analyze suspected abnormal reactions to vaccination;

　　(5) Failing to take out compulsory vaccine liability insurance as required;

　　(six) the information disclosure system is not established in accordance with the provisions.

　　Article 84 If a batch issuing institution violates the provisions of this Law in any of the following circumstances, the drug supervision and administration department of the State Council shall order it to make corrections and give it a warning, and the principal responsible person, the directly responsible person in charge and other directly responsible personnel shall be given a warning according to law until demotion:

　　(1) Failing to conduct examination and inspection in accordance with the provisions;

　　(2) Failing to announce the results of batch issuance of vaccines on the market in time;

　　(3) Failing to verify in accordance with the provisions;

　　(4) Failing to report the major quality risks of the vaccine as required.

　　If, in violation of the provisions of this Law, the batch issuing institution fails to issue a batch issuing certificate or refuses to issue a batch issuing notice in accordance with the provisions, the drug supervision and administration department of the State Council shall order it to make corrections, give it a warning, and demote or dismiss the principal responsible person, the directly responsible person in charge and other directly responsible personnel according to law; If the circumstances are serious, the principal responsible person, the directly responsible person in charge and other directly responsible personnel shall be dismissed according to law.

　　Article 85 If disease prevention and control institutions, inoculation units, vaccine marketing license holders and vaccine distribution units violate the requirements of cold chain storage and transportation in the management norms for vaccine storage and transportation, the pharmaceutical supervisory and administrative department of the people’s government at or above the county level shall order them to make corrections, give them a warning, destroy the illegally stored and transported vaccines and confiscate their illegal income; Refuses to correct, the vaccination units, vaccine marketing license holders, vaccine distribution units at more than two hundred thousand yuan to one million yuan fine; If the circumstances are serious, the vaccination units, vaccine marketing license holders and vaccine distribution units shall be fined for illegally storing and transporting vaccines for more than 10 times and less than 30 times. If the value is less than 100,000 yuan, the vaccine marketing license holders and vaccine distribution units shall be ordered to stop production and suspend business for rectification until the relevant approval documents and drug production licenses are revoked, and the legal representatives, principals and direct responsibilities of the vaccine marketing license holders and vaccine distribution units shall be directly responsible.

　　If the disease prevention and control institutions and inoculation units commit illegal acts as prescribed in the preceding paragraph, the competent health department of the people’s government at or above the county level shall give a warning to the main person in charge, the directly responsible person in charge and other directly responsible personnel according to law until they are dismissed, and order the responsible medical and health personnel to suspend their practice activities for more than one year and less than 18 months; If serious consequences are caused, the principal responsible person, the directly responsible person in charge and other directly responsible personnel shall be dismissed according to law, and the inoculation qualification of the inoculation unit may be revoked, and the practice certificate of the responsible medical and health personnel shall be revoked by the original issuing department.

　　Article 86 If disease prevention and control institutions, inoculation entities, vaccine marketing license holders and vaccine distribution entities violate the management norms of vaccine storage and transportation other than those specified in Article 85 of this Law, the pharmaceutical supervisory and administrative department of the people’s government at or above the county level shall order them to make corrections, give them a warning and confiscate their illegal income; Refuses to correct, the vaccination units, vaccine marketing license holders, vaccine distribution units at more than one hundred thousand yuan to three hundred thousand yuan fine; If the circumstances are serious, the vaccination unit, vaccine marketing license holder and vaccine distribution unit shall be fined for illegally storing and transporting vaccines with a value of more than three times and less than ten times. If the value is less than 100,000 yuan, it shall be calculated as 100,000 yuan.

　　If the disease prevention and control institutions and vaccination units commit illegal acts as prescribed in the preceding paragraph, the health department of the people’s government at or above the county level may give warning to the principal responsible person, the directly responsible person in charge and other directly responsible personnel according to law until dismissal, and order the responsible medical and health personnel to suspend their practice activities for more than six months and less than one year; If serious consequences are caused, the principal responsible person, the directly responsible person in charge and other directly responsible personnel shall be dismissed according to law, and the practice certificate of the responsible medical and health personnel shall be revoked by the original issuing department.

　　Article 87 If a disease prevention and control institution or vaccination unit violates the provisions of this Law in any of the following circumstances, the competent health department of the people’s government at or above the county level shall order it to make corrections, give it a warning and confiscate its illegal income; If the circumstances are serious, the principal responsible person, the directly responsible person in charge and other directly responsible personnel shall be given a warning until dismissal, and the responsible medical and health personnel shall be ordered to suspend their practice activities for more than one year and less than 18 months; If serious consequences are caused, the principal responsible person, the directly responsible person in charge and other directly responsible personnel shall be dismissed according to law, and the practice certificate of the responsible medical and health personnel shall be revoked by the original issuing department:

　　(1) Failing to supply, receive or purchase vaccines as required;

　　(two) vaccination did not comply with the vaccination work norms, immunization procedures, vaccine use guidelines, vaccination program;

　　(three) unauthorized mass vaccination.

　　Article 88 If a disease prevention and control institution or vaccination unit violates the provisions of this Law in any of the following circumstances, the competent health department of the people’s government at or above the county level shall order it to make corrections and give it a warning; If the circumstances are serious, the principal responsible person, the directly responsible person in charge and other directly responsible personnel shall be given a warning until dismissal, and the responsible medical and health personnel shall be ordered to suspend their practice activities for more than six months and less than one year; If serious consequences are caused, the principal responsible person, the directly responsible person in charge and other directly responsible personnel shall be dismissed according to law, and the practice certificate of the responsible medical and health personnel shall be revoked by the original issuing department:

　　(1) Failing to provide traceability information as required;

　　(2) Failing to obtain and keep relevant certification documents and temperature monitoring records in accordance with regulations when receiving or purchasing vaccines;

　　(3) Failing to establish and keep records of vaccine receipt, purchase, storage, distribution, supply, inoculation and disposal in accordance with regulations;

　　(4) Failing to inform or ask the recipient or his guardian about the situation in accordance with the regulations.

　　Article 89 If disease prevention and control institutions, vaccination units and medical institutions fail to report suspected abnormal vaccination reactions and vaccine safety incidents in accordance with regulations, or fail to organize investigation and diagnosis of suspected abnormal vaccination reactions in accordance with regulations, the competent health department of the people’s government at or above the county level shall order them to make corrections and give them a warning; If the circumstances are serious, the vaccination units and medical institutions shall be fined between 50,000 yuan and 500,000 yuan, and the principal responsible persons, directly responsible personnel in charge and other directly responsible personnel of the disease prevention and control institutions, vaccination units and medical institutions shall be given a warning according to law until dismissal; If serious consequences are caused, the principal responsible person, the directly responsible person in charge and other directly responsible personnel shall be dismissed according to law, and the practice certificate of the responsible medical and health personnel shall be revoked by the original issuing department.

　　Article 90 If a disease prevention and control institution or vaccination unit collects fees in violation of the provisions of this Law, the competent health department of the people’s government at or above the county level shall supervise it to return the illegally collected fees to the unit or individual who originally paid the fees, and the market supervision and management department of the people’s government at or above the county level shall punish it according to law.

　　Article 91 Anyone who, in violation of the provisions of this Law, engages in immunization planning vaccination without being designated by the competent health department of the local people’s government at or above the county level, or engages in non-immunization planning vaccination that does not meet the requirements or has not been put on record, shall be ordered by the competent health department of the people’s government at or above the county level to make corrections, give a warning, confiscate the illegal income and illegally held vaccines, be ordered to suspend business for rectification, and be fined not less than 100,000 yuan but not more than 1 million yuan. The principal responsible person, the directly responsible person in charge and other directly responsible personnel shall be punished according to law.

　　In violation of the provisions of this law, units or individuals other than disease prevention and control institutions and vaccination units carry out mass vaccination without authorization, and the health authorities of the people’s governments at or above the county level shall order them to make corrections, confiscate the illegal income and illegally held vaccines, and impose a fine of not less than 10 times but not more than 30 times the value of illegally held vaccines. If the value is less than 50,000 yuan, it shall be calculated as 50,000 yuan.

　　Ninety-second guardians who fail to ensure that school-age children are vaccinated on time according to law shall be criticized and educated by the health authorities of the people’s government at the county level and ordered to make corrections.

　　Nursery institutions and schools that fail to check vaccination certificates in accordance with the regulations when children enter kindergartens and schools, or fail to report to the vaccination unit after discovering children who have not been vaccinated in accordance with the regulations, the education administrative department of the local people’s government at or above the county level shall order them to make corrections, give them a warning, and punish the principal responsible person, the directly responsible person in charge and other directly responsible personnel according to law.

　　Article 93 Whoever fabricates or disseminates false vaccine safety information, or makes trouble in the inoculation unit, which constitutes a violation of public security administration, shall be punished by the public security organ according to law.

　　Newspapers, periodicals, radio, television, Internet sites and other media fabricate and disseminate false information about vaccine safety, and the relevant departments shall punish them according to law, and the principal responsible person, the directly responsible person in charge and other directly responsible personnel shall be punished according to law.

　　Article 94 If the local people’s governments at or above the county level have any of the following circumstances in vaccine supervision and management, the directly responsible person in charge and other directly responsible personnel shall be demoted or dismissed according to law; If the circumstances are serious, he shall be dismissed according to law; Causing serious consequences, the main person in charge shall resign:

　　(a) ineffective performance of duties, resulting in serious adverse effects or heavy losses;

　　(2) Concealing, misrepresenting, delaying or omitting vaccine safety incidents;

　　(3) Interfering with or obstructing the investigation of vaccine violations or vaccine safety incidents;

　　(four) a particularly serious vaccine safety accident occurred in the administrative area, or a series of major vaccine safety accidents occurred.

　　Article 95 If the drug supervision and administration department, health department and other departments have any of the following circumstances in vaccine supervision and management, the directly responsible person in charge and other directly responsible personnel shall be demoted or dismissed according to law; If the circumstances are serious, he shall be dismissed according to law; Causing serious consequences, the main person in charge shall resign:

　　(a) failing to perform the duties of supervision and inspection, or failing to investigate and deal with illegal acts in time;

　　(two) unauthorized mass vaccination;

　　(3) Concealing, misrepresenting, delaying or omitting vaccine safety incidents;

　　(4) Interfering with or obstructing the investigation of vaccine violations or vaccine safety incidents;

　　(5) divulging the information of informants;

　　(six) received a report on the suspected abnormal reaction to vaccination, and failed to organize the investigation and handling in accordance with the provisions;

　　(seven) other acts that fail to perform the duties of vaccine supervision and management, resulting in serious adverse effects or heavy losses.

　　Article 96 If the vaccine quality problem causes damage to the recipients, the holder of the vaccine marketing license shall be liable for compensation according to law.

　　Disease prevention and control institutions and vaccination units that violate vaccination work norms, immunization procedures, guiding principles for the use of vaccines, and vaccination programs, causing damage to the recipients, shall be liable for compensation according to law.

Chapter XI Supplementary Provisions

　　Article 97 The meanings of the following terms in this Law are:

　　Immunization vaccines refer to vaccines that residents should be vaccinated in accordance with government regulations, including vaccines determined by the national immunization program, vaccines added by the people’s governments of provinces, autonomous regions and municipalities directly under the Central Government when implementing the national immunization program, and vaccines used for emergency vaccination or mass vaccination organized by the people’s governments at or above the county level or their health authorities.

　　Non-EPI vaccines refer to other vaccines voluntarily vaccinated by residents.

　　The holder of vaccine marketing license refers to an enterprise that has obtained the registration certificate of vaccine drugs and the drug production license according to law.

　　Article 98 The State encourages vaccine production enterprises to produce and export vaccines in accordance with international procurement requirements.

　　The exported vaccine shall meet the standards or contract requirements of the importing country (region).

　　Article 99 Entry-exit vaccination and procurement of required vaccines shall be separately stipulated by the frontier health and quarantine organ in consultation with the financial department of the State Council.

　　Article 100 This Law shall come into force as of December 1, 2019.

　　The Double Ninth Festival in Sihui City "Zhenxian Birthday"

　　Time: October 7, 2019

　　2019 Guangdong Dragon and Lion Championship

　　Time: July

　　2019 Guangdong Billiards Championship

　　Time: September

　　2019 National Rowing Championships

　　Time: September 8, 2019—September 13, 2019.

　　According to the requirements of the Regulations of People’s Republic of China (PRC) Municipality on the Openness of Government Information (the State Council Order No.492, hereinafter referred to as the Regulations) and the Notice on Further Improving the Compilation and Release of the Annual Report on Government Information Disclosure (Guo Ban Kai Letter [2016] No.14), the 2015 annual report of the Ministry of Finance on government information disclosure is hereby released to the public. The full text includes an overview, proactive disclosure of government information, practical promotion of information disclosure in key areas, serious disclosure according to application, strengthening the construction of information disclosure platform, major problems and improvement measures, etc. The data statistics period is from January 1, 2015 to December 31, 2015. This report can be found on the portal website of the Ministry of Finance (www.mof.gov.cn, hereinafter referred to as the portal website). If you have any questions about this report, please contact the Financial Information Disclosure Office of the General Office of the Ministry of Finance (address: No.3, South Third Lane, Sanlihe, Xicheng District, Beijing, zip code: 100820, telephone number: 68551570, and fax).

　　I. Overview

　　In 2015, according to the Notice of the General Office of the State Council on Printing and Distributing the Main Points of Government Information Disclosure in 2015 (Guo Ban Fa [2015] No.22), the Ministry of Finance strengthened the construction of portal website columns and government WeChat platform, and made full use of portal website, WeChat WeChat official account, Ministry of Finance proclamation, news media, newspapers and periodicals yearbook and other forms to announce fiscal policies and financial data to the public in a timely and proactive manner. We will comprehensively promote the disclosure of information in key areas such as the central financial budget and final accounts, the use of financial funds, administrative examination and approval, and government procurement, conscientiously handle matters that are disclosed upon application, and actively do a good job in policy interpretation and response, further expanding and refining the scope and content of financial information disclosure, and enhancing the timeliness and influence of financial information disclosure.

　　II. Proactive disclosure of government information

　　The Ministry of Finance regards the voluntary disclosure of government information as an important means to promote administration according to law, financial management according to law and the construction of service-oriented institutions. For government information that is voluntarily disclosed, it shall be disclosed within 20 working days from the date when the information is formed or changed, such as newly issued financial regulations, rules and normative documents. The national financial revenue and expenditure, the national lottery sales and the economic operation of state-owned and state-controlled enterprises have been published on the portal website on a monthly basis. The timely disclosure of special work was realized: on March 24, 2015, the national land transfer revenue and expenditure in 2014 was disclosed, and on November 27, the national science and technology investment bulletin in 2014 was published. In 2015, more than 180,000 pieces of information were published through portals and mobile websites, and more than 2,100 pieces of information were published through government WeChat. The average daily page views of portals exceeded 2 million, and the number of government WeChat subscribers was nearly 500,000. Published 12 issues of the Ministry of Finance Proclamation and published 164 policy documents.

　　Third, effectively promote information disclosure in key areas

　　(1) Promoting the information disclosure of financial funds.

　　The first is the disclosure of the central government’s budget and final accounts. In 2014, on the basis of the classification of expenditure function items, in 2015, the basic expenditure was disclosed to the economic classification items. On the basis of the disclosure of special transfer payments to specific projects, the budget of tax refund, general transfer payments and special transfer payments in different regions has been increased. On the same day, 100 central departments made public the departmental budget and final accounts and the "three public" funds budget and final accounts. On March 17, 2015, the Ministry of Finance published the Report on the Implementation of the Central and Local Budgets in 2014 and the Draft Central and Local Budgets in 2015 through the portal website; On March 25th, the central budget for 2015 was made public; On June 29th, the Report on the Final Accounts of the Central Government in 2014 was made public; On July 10, the 2014 national financial final accounts were made public; On July 17th, the Ministry of Finance organized the central department to make public to the public for the first time a number of legal and social information such as final accounts data of expenditure economic classification subjects, summary of financial appropriation income and expenditure, government procurement expenditure, operating expenses of government agencies, and occupation of state-owned assets, which won favorable comments from public opinion and the public. On November 16th, the Notes on the Final Accounts of the National Social Insurance Fund in 2014 was published.

　　The second is the disclosure of the central "three public" funds budget and final accounts. Actively coordinate the central departments to do a good job in publicizing the budget and final accounts of the "three public" funds. In the budget and final accounts made public by the central government in 2015, the expenditure table of "three public funds" and the final account table of "three public funds" were set up respectively, which reflected in detail the budget arrangement of "three public funds" and the implementation of the previous year, and further refined the "official vehicle purchase and operation fee" into "official vehicle purchase fee" and "official vehicle operation fee", and made them public for the first time. On April 17, 2015, the budget implementation of the "three public funds" in 2014 and the budget arrangement in 2015 were made public through the portal website. On June 28th, with the final report of the central government in 2014, the expenditures of the "three public funds" at the central level in 2014 were disclosed.

　　The third is the disclosure of national budget implementation information and local budget and final accounts. Set up "financial data" and "national financial revenue and expenditure" columns on the portal website, timely release the implementation of the national financial budget on a monthly basis, and actively explain the hot issues that may cause social concern in the operation of revenue and expenditure, and respond to public concern. Make unified arrangements and requirements for the subject, time, form and content of local budget and final accounts disclosure, make special reports on local budgets and final accounts of provinces (autonomous regions and municipalities directly under the Central Government), and make them publicly available in the "Special Review" column of the portal website. The Notice on Special Inspection of the Disclosure of Local Budgets and Accounts (No.84 [2015] of Finance Supervision) was issued, and special inspections were carried out on the timeliness, completeness and detail of the disclosure of local budgets and accounts. According to the relevant work arrangement of China’s accession to the International Monetary Fund (IMF) Special Data Dissemination Standard (SDDS), the Ministry of Finance began to publish the monthly revenue and expenditure, financing data and quarterly debt balance data of the central government on a regular basis in mid-2015.

　　(two) to promote the information disclosure of financial administrative examination and approval. First, a column "Reform of Administrative Examination and Approval System" was set up on the portal website, and information such as policies and systems related to administrative examination and approval, financial administrative examination and approval items, and the progress of the reform of the examination and approval system were published in a centralized manner, so as to facilitate the public to obtain administrative examination and approval information in a timely manner. Second, in accordance with the requirements of the State Council’s Decision on Cancelling and Adjusting a Batch of Administrative Approval Items (Guo Fa [2015] No.11), the information of administrative approval for canceling adjustment was released in time. In 2015, five administrative approval items involving the Ministry of Finance cancelled by the State Council were all made public on the portal website, which promoted the implementation and orderly connection of the cancellation of decentralization of approval items. The third is to actively promote the disclosure of relevant information on administrative licensing. Open the "Online Administrative Examination and Approval" column on the portal website, fully disclose the setting basis of administrative license, and promote the disclosure of information such as the conditions, procedures, quantity and the catalogue of materials to be submitted for the implementation of license. Some flowcharts of administrative licensing matters have been made public on the portal website.

　　(3) Promoting the disclosure of government procurement information. First, on February 25, 2015, the Key Points of Government Procurement in 2015 was published, so as to let the public know the key points of government procurement in time and enhance the transparency of government procurement. The second is to implement the relevant provisions of the Regulations on the Implementation of the Government Procurement Law and improve the specific operating system of government procurement information disclosure. On July 17, 2015, the Notice of the Ministry of Finance on Doing a Good Job in Government Procurement Information Disclosure (Caiku [2015] No.135) was issued, which clarified the disclosure scope of various government procurement information, standardized the disclosure channels, and refined the disclosure requirements, which effectively promoted the disclosure of government procurement information. The third is to strengthen the operation and management of China government procurement network, improve the column setting, and timely disclose government procurement information, especially the information on bidding, winning the bid and correcting. Standardize the release and update of government procurement information content.

　　(4) Promoting the information disclosure of national debt and local government bonds. First, in the "Treasury Bond Management" column of the portal website, at the beginning of the year, the annual book-entry treasury bond bidding and issuance rules, savings bonds issuance quota management measures, key-term treasury bonds, 50-year treasury bonds, and savings bonds issuance plans were announced, and the debt service information of annual treasury bonds and local government bonds paid by the Ministry of Finance was announced; At the end of each quarter, announce the issuance plan of all national debt for the next quarter; Announce the issuance notice of book-entry treasury bonds 1 or 5 working days before the tender, and announce the issuance announcement on the day of the end of the tender; Announce the announcement of savings bonds’s issuance 5 working days before the issuance. Second, based on the release of the yield curve of key-term government bonds in 2014, the three-month and six-month government bond yields will be released in 2015 to provide a benchmark for financial market pricing. The third is to publish the relevant institutional measures for the issuance management of local government bonds on the portal website, and further improve the information disclosure system of local government bonds, such as information disclosure before issuance, issuance results disclosure, duration information disclosure, major events disclosure, and debt service disclosure. Guide the financial departments of local governments to do a good job in information disclosure of local government bonds according to regulations.

　　(five) the publicity of the results of the NPC deputies’ suggestions and CPPCC members’ proposals. In 2015, the Ministry of Finance made great efforts to improve the working mechanism, strengthen supervision and supervision, and consider, deploy and promote the handling of NPC deputies’ proposals and CPPCC members’ proposals together with business work as an important means to promote financial work, an important platform to build consensus, and an important channel to enhance understanding and support. In 2015, the Ministry of Finance handled a total of 4,103 proposals, of which 2,506 were proposed by representatives and 489 were sponsored. There were 1597 members’ proposals and 333 sponsors; A total of 38 key proposals were identified and 15 related policies and measures were introduced. In the portal "Suggestions" column, 57 summaries of 2014 replies were published.

　　Four, seriously handle the disclosure according to the application.

　　Establish "centralized acceptance and decentralized handling; The government information of "one order to the end, the whole process of tracking" is handled in public according to the application mechanism, and the standardized workflow of six steps, such as application acceptance, elements review, distribution, tracking and coordination, information provision and data archiving, is strictly implemented, and a system for handling government information in public according to the application is developed, which digitizes all links of acceptance, transfer, reply and archiving to realize the whole process. In 2015, a total of 145 applications for government information disclosure were received, all of which were handled in accordance with relevant laws and regulations. Received 17 cases of information disclosure reconsideration with the Ministry of Finance as the respondent, and 13 cases of information disclosure litigation with the Ministry of Finance as the defendant and the specific behavior as the main body. This year, the Ministry of Finance did not collect fees from applicants for government information disclosure.

　　Five, strengthen the construction of information disclosure platform

　　(1) Improve the information content support system. Implement the "Opinions of the General Office of the State Council on Strengthening the Construction of Government Website Information Content" (Guo Ban Fa [2014] No.57) and the "Notice of the General Office of the State Council on Carrying out the First National Government Website Survey" (Guo Ban Fa [2015] No.15), pay close attention to the construction of portal website information content, and strive to improve the management level of portal website. Issued the "Notice on Further Improving the Information Content Construction of the Portal of the Ministry of Finance" to all units in the Ministry and local Commissioner’s Offices, strengthened the information release and update of the portal, and standardized the information release process of the portal. Earnestly carry out the general survey of the portal website and the China municipal government procurement network, do a good job in the investigation and information reporting, and earnestly do a good job in rectification. A total of 276 invalid links and 12 "sleep" columns were cleared in the sub-stations run by departments and commissioners.

　　(2) Improve the website information collection mechanism. Adhere to the monthly statistical bulletin portal departments, the Commissioner’s office, the provinces (autonomous regions and municipalities) finance department (bureau) sub-channel content security evaluation score, enhance the enthusiasm of each unit to upload information actively. The Ministry of Finance portal website sub-channels of some key information release schedule in 2015 was issued. On this basis, the information release task was decomposed into months, and letters were sent to various departments at the beginning of each month, and checked and coordinated at the end of each month, so as to effectively strengthen the organization and guidance for the information release of sub-channels of various departments of the portal website.

　　(3) Strict information release review. Establish an information release mechanism of "clear division of labor, clear rights and responsibilities, multi-person review and step-by-step control", and strictly review information release to ensure timely and accurate release of authoritative information. For key information such as financial news and photo news, the policy, text and figures are strictly controlled, and sensitive matters are repeatedly communicated with relevant units for revision.

　　(4) Strengthen financial news propaganda. Pay attention to the use of financial news publicity platform to improve the effect of financial information disclosure. Considering and arranging fiscal policy interpretation and fiscal policy formulation synchronously, the leaders of the organization department attended more than 30 press conferences (including briefings), interviews with Chinese government websites and joint interviews with journalists, organized relevant departments to hold press conferences (including briefings) and carry out policy interpretation for more than 40 times, and publicized the background, objectives and main points of the fiscal policy in various forms such as digitalization, charts and diagrams. Carefully use the international financial conferences attended by the Ministry of Finance, such as the 48th annual meeting of the ADB Board of Directors, the signing ceremony of the articles of association of the AIIB, the seventh special meeting of China-US Strategic and Economic Dialogue, and the G20 meeting of finance ministers and central bank governors, to be interviewed by the international mainstream media on issues of international concern, to publicize the healthy development of China’s economy, and to announce the development and achievements of China’s fiscal reform.

　　VI. Main Problems and Improvement Measures

　　In 2015, the work of financial information disclosure has achieved certain results, but there are still some problems such as the scope of disclosure needs to be expanded, the content of disclosure needs to be refined, and the construction of open platform needs to be strengthened. In 2016, the Ministry of Finance will focus on the following aspects:

　　(1) Further expand the scope of financial information disclosure. Conscientiously implement the "Opinions on Comprehensively Promoting the Openness of Government Affairs", adhere to the principle of openness as the norm and non-openness as the exception, closely focus on economic and social development and people’s concerns, continuously expand the scope of financial information disclosure, and strengthen financial information release and policy interpretation.

　　(two) to further improve the public budget and final accounts. Timely disclosure of reports and statements (except confidential information) on budgets, budget adjustments, budget implementation and final accounts approved by the People’s Congress and its Standing Committee according to law; All expenditures on budget and final accounts are disclosed to functional classification item-level subjects (except classified information) and to economic classification subjects (except classified information) according to regulations; Make public the tax refund, general transfer payment and special transfer payment in different regions, and make public the budget and final accounts of the next special transfer payment according to specific projects; All departments and units shall make public final accounts, indicating the number and number of delegations going abroad on business, the number and quantity of official vehicles purchased, and the batch and number of domestic official receptions.

　　(three) to further promote the disclosure of administrative examination and approval information. Timely disclose the application conditions, quantity, procedures and time limit of licensing matters, as well as all materials and information to be submitted when applying. Timely public cancellation, decentralization and implementation of administrative examination and approval project information.

　　(four) to further promote the disclosure of government procurement information. Do a good job in the information disclosure related to the whole process of government procurement, and disclose the overall situation of government procurement budget arrangement and procurement implementation in accordance with the requirements of public financial budget and final accounts. Make the disclosure of government procurement information an important part of supervision and inspection, and investigate the responsibility of purchasers and procurement agencies who fail to release government procurement project information according to law.

　　(V) Further strengthen the construction of the financial information disclosure platform. Strengthen the construction of the standard system of information disclosure catalogue, further improve the column setting of portal website, improve the mechanism of information content collection, review and release, and optimize the information query method. Make full use of new media such as WeChat WeChat official account to broaden the channels of information dissemination, enrich the content of WeChat information, and innovate the display forms of WeChat to meet the diverse information needs of different groups.

Wen | Xianfeng Chuang (ID:xianfengk2vc), by Zhang Runtao

Core point of view:

1. 【 Macro Pattern 】The size of China’s automobile aftermarket is 1.2 trillion, which is about half that of the United States, but the number of auto parts manufacturers, auto parts distribution channels and maintenance service enterprises is twice that of the United States. On the whole, China’s automobile aftermarket is in the form of "ant market", and there are obvious opportunities for integration in all aspects.

At present, the core contradiction between supply and demand in the automobile aftermarket is not the inefficient matching of traffic, but the low efficiency of the supply chain of automobile parts and the low quality of maintenance services. Therefore, it is difficult for giants (Ali, Tencent, JD.COM, Baidu, Didi, Guazi, Manbang) who use traffic to bless the track to quickly end the war in a short time by means of user subsidies, and emerging startups can still break through with their own unique advantages.

2. [Opportunities and Methods]Driven by two forces on the demand side (a large number of cars leave the maintenance period+consumption upgrade) and three forces on the supply side (due to the mature productivity trained for OEM in Europe and America+excellent scale effect of China’s auto parts circulation channels+mature technical infrastructure of maintenance services), China’s automobile aftermarket will systematically spawn a variety of entrepreneurial-investment opportunities, and startup companies can learn from the 13 methods mentioned in this paper to create long-term value and become industry unicorns.

3. [Valuation System and Growth Timeline]Venture companies interested in contacting VC capital can aim at "becoming a unicorn of 1 billion dollars in 8 years" and benchmark the valuation system of listed companies in the US stock market, so as to push back their own business rhythm and team configuration.

When will unicorns come out of China automobile aftermarket? This is a topic that entrepreneurs and investors often discuss in the industrial upgrading track.

On the one hand, Auto Zone, Advance Auto Parts, O’Reilly and NAPA, the four major chains in the field of auto parts in the United States, stand at a market value of tens of billions of dollars, and there are unicorns with a market value of billions of dollars in the field of maintenance services, such as Monro Muffler Brake and Valvoline, but there is no listed giant in China that can compete with them in the same amount.

On the other hand, Internet giants such as BAT/ JD.COM/Didi have been exploring the post-steam for a long time, and star startups such as Kangzhong/Batulu/Kaisi have also been in the post-steam battlefield for many years. However, at present, the whole post-steam competition pattern in China is not clear, and new players are still eager to try with their own unique resources.

These two characteristics make new entrepreneurs and investors always reluctant to take their eyes off the automotive aftermarket in China.

This paper tries to analyze the present situation and future of China automobile aftermarket from the perspective of Top-Down — —

Part.1　　The Market Size and product-service categories of automobile aftermarket are presented in an overview;

Part.2　　This paper systematically analyzes the competitive pattern of automobile aftermarket from three aspects: macro supply system, core track players and giant layout.

Part.3　This paper introduces the macro trend that affects the automobile aftermarket, and gives 13 "tricks" to achieve the unicorn after automobile in the future;

Part.4　From the perspective of capital market, this paper shows the valuation system of post-automobile companies with examples, and discusses the method of reversing the growth timeline of enterprises based on this.

I hope this article can bring some reference value to entrepreneurs, industry professionals and friends who are concerned about the post-steam industry, and welcome friends who are interested in this topic to exchange and discuss.

I. Market Size

In 2018, the automobile aftermarket in China is about 1.2 trillion, including 780 billion auto parts (65%) and 420 billion maintenance services (35%).

Automobile aftermarket size = car ownership × average car consumption, divided into two core elements — —

1. Car ownership

In 2018, the number of cars in China was 240 million (including passenger cars and commercial vehicles), with a growth rate of 10.6% (the number of new cars in 2018 was 28.08 million, down 3% year-on-year). Although the number of new car transactions declined, the overall number of cars will continue to rise in the future.This data can also be confirmed from the car ownership of thousands of people — — As can be seen from the figure below, China’s car ownership of 1,000 people is not only far lower than that of developed countries such as the United States and Japan, but also lower than that of many developing countries, and there is still room for increasing car ownership in the future.　

The number of P.S. cars with 1,000 people depends on population density, economic level, public transportation level and other factors, so I won’t analyze them here. The above large numbers are only for reference.

2. Average car consumption amount

In 2018, the average car consumption of China Automobile for maintenance was about 5,000 yuan; This variable is positively related to the average age of cars. At present, the average age of cars in China is 5 years, and it will inevitably increase in the future.

Based on the two basic driving forces, namely, the increasing number of cars in China and the increasing age of cars, it is expected that the future automotive aftermarket will be in the growing trillion-dollar volume for a long time.

Second, product & service category

The final deliverables in the automotive aftermarket include [auto parts] and [maintenance services].

1. Auto parts

Auto parts refer to all the parts that make up a car; According to the maintenance or replacement cycle, auto parts are usually divided into two categories: [wearing parts] and [whole vehicle parts] — —

① Wearable parts

Wearable parts refer to accessories that must be repaired or replaced after a certain mileage or time. Typical categories of wearing parts include: engine oil, gearbox oil, brake oil, tires, engine oil filter, air filter, air conditioning filter, gasoline filter, spark plug, antifreeze, brake pads, brake discs, etc.

② Complete vehicle parts

　Whole vehicle parts refer to the parts that must be repaired or replaced after an accident. Typical whole vehicle parts include: engine, bumper, gearbox, oil cylinder and so on.

Due to the numerous manufacturers of various brands, and the characteristics of many cars, models and models under each brand, the number of SKUs of auto parts is huge — — At present, the average SKU of automobile spare parts is about 30,000, and the overall SKU of automobile spare parts is more than 50 million. This is a huge SKU volume for a single industry, but looking at the breakdown of wearing parts and whole car parts categories:Wearable parts are universal (for example, different models can share the same specification of engine oil), so the effect of collecting orders is obvious for players who are trading platforms, and they are relatively suitable for self-operation; The universality of the whole vehicle is weak, so the effect of collecting orders is not obvious for players who are trading platforms, and it is relatively suitable for third-party infrastructure (Marketplace, logistics, supply chain finance, etc.).

2. Maintenance service

Maintenance service refers to the human service of automobile parts maintenance or replacement and beauty care. Usually, the maintenance or replacement of beauty care and wearing parts is a high-frequency service item, and the maintenance or replacement of whole automobile parts is a low-frequency service item.

At present, the size of China’s automobile aftermarket is about 1/2 that of the United States (the car ownership of the two countries is similar, but the average age of the car in the United States is twice that of China+), but the number of auto parts manufacturers, auto parts distribution channels and maintenance service enterprises is twice that of the United States — —On the whole, the post-steam market in China is in a relatively scattered "ant market" form, and the quality and efficiency of products and services are uneven, so there are obvious opportunities for integration.

First, the macro supply system

Because there are two core factors in China: ① few car owners master maintenance technology and ② low labor cost, 95% of maintenance services are provided by 4S shops and repair shops, and only 5% of car owners will choose to repair their own cars; Therefore, [automotive aftermarket] has also formed two core circulation paths based on this:

A.4S shop system (accounting for 20%): auto parts manufacturer authorized by the main engine factory → Main engine factory after-sales department → 4S shop → Consumers;

B. Independent post-market system (accounting for 75%): &rarr, an auto parts manufacturer not authorized by the OEM; Agent → Dealer → Auto parts city retailer → Repair shop → Consumers.

The following describes the basic status quo of three types of supply roles: auto parts manufacturers, auto parts distribution channels and service terminals — —

1. Auto parts manufacturers

① Auto parts manufacturer authorized by the OEM (original parts)

This kind of auto parts manufacturers have formed a long-term and stable cooperative relationship with automobile brand manufacturers, such as Denso in Japan, Bosch in Aisin Germany and Mainland China, which produce auto parts according to the design requirements of automobile brand manufacturers, put on the Logo of automobile brand and sell them to automobile brand manufacturers, and then circulate them to 4S stores.

Such manufacturers represent the most advanced supply chain level of auto parts in terms of quality and efficiency, and because of the profit margin requirements of automobile brand manufacturers and 4S shop system, the brand premium of auto parts of such manufacturers is often very high when they are circulated to consumers.

② Auto parts manufacturers not authorized by the OEM.

This kind of auto parts manufacturers can be roughly divided into three categories — —

Class A (factory parts): Class A manufacturers are completely auto parts manufacturers authorized by the OEM, but they sell another part of their production capacity to the independent post-market (without the Logo of the automobile brand), but the supply chain system behind them is exactly the same. Because the premium of automobile brand is removed, the price of such accessories in the independent market is 20%~30% cheaper than that in the 4S shop system, so it is the best choice for consumers in the independent market.

Class B (sub-factory parts): evolved from the foundry of Class A manufacturer. In the process of OEM for international brands, Class B manufacturers have mastered the skilled supply chain technology (especially in the more general consumable parts category). In order to expand their own revenue and profits, they often choose to create their own brands and sell them to the circulation channels of the independent market system. The quality and efficiency of Class B manufacturers in many auto parts categories are almost the same as those of international brands, so it is the second best choice in the post-independence market system.

Class C (spare parts): a "self-reliant" manufacturer that has no direct relationship with the auto parts manufacturer authorized by the main engine factory. Relying on the research of auto parts in the market and close contact with Class B manufacturers, these manufacturers indirectly mastered the supply chain technology of auto parts, and based on this, they created their own brands and sold them to the circulation channels of the independent market system. Class C manufacturers are weaker than Class A in quality and efficiency, but they can still meet the needs of most parts in automobile aftermarket service.

2. Distribution channels of auto parts

① OEM after-sales department

The after-sales department of the main engine factory is also the after-sales department of automobile brand manufacturers, which purchases automobile parts from authorized manufacturers and sells them to 4S stores at a higher price. Because the 4S shop has the brand premium authorized by the automobile manufacturer, and the automobile manufacturer decides the supply of auto parts in the 4S shop by policy instructions, the main engine factory often sells it to the 4S shop with a higher gross profit (the gross profit is higher than that of the same quality parts).

② Market circulation channels after independence.

After independence, the circulation channel of the market is consistent with the general commodity circulation system, mainly including three core links: agency, distribution and retail. The upstream of the whole circulation channel is the auto parts manufacturer authorized by the non-OEM, and the downstream is the repair shop. Because the repair shop has almost no brand premium, and there are many distribution channels in the domestic market after independence, the agents, dealers and retailers here often have relatively low price increase rates — — The gross profit margin of the distribution channel of general wearing parts is 20%~30%, and the gross profit margin of the distribution channel of whole vehicle parts is 30%~45%.

Note that the two types of circulation channels are now "merging", which is manifested in:

A. 4S shop purchases auto parts from independent market circulation channels.

The core reason is that the newly implemented "Measures for the Administration of Automobile Sales" in July 2017 allows some non-original parts to enter the 4S shop system, which enables agents, dealers and retailers who originally operated in the independent post-market system to serve as additional parts channels for 4S shops.

B the repair shop purchases auto parts from the 4S shop and the after-sales department of the main engine factory.

The core reason is that the operating performance of 4S stores has generally declined in recent years, and the liquidity of auto parts originally circulated in the 4S store system has declined, resulting in more inventory. In order to digest these inventories, 4S stores and the after-sales department of the main engine factory will sell them to repair shops.

3. Service terminal

① 4S shop

4S shop was first introduced to China by Guangzhou Honda in 1998, and now it has become the most important system in China’s new car circulation network. The two most important functions of 4S stores are: first, new car sales, and second, after-market service (mainly to undertake the maintenance service demand within the three-year maintenance period or a certain mileage maintenance period). According to the profit structure, about 20% of China 4S stores’ profits come from new car sales, and the remaining 80% comes from after-market service, which is equivalent to the profit structure of American car dealers.

② Repair shop

Different from the 4S shop, the repair shop will undertake the maintenance services of many brands of cars, and the repair price of the repair shop is relatively low due to competitive factors and weak brand premium (including auto parts and maintenance services are cheaper than those of the 4S shop).

China’s Ministry of Communications conducts certification examination for repair technicians in repair shops every year, but there is no strict high-standard system for qualification examination as a whole, so the overall service level of repair shops in China is still uneven (the service level < mean > can meet most of the automobile maintenance needs, but the variance < variance > fluctuates greatly).

It is worth noting that 4S stores and repair shops are excellent channels for selling automobile insurance because they have excellent customer resources, so many insurance companies will have a binding relationship with 4S stores and repair shops (M×N multiple binding relationship) and cross-sell each other’s products and services &mdash; &mdash; 4S shops and repair shops recommend car owners to buy a company’s insurance, and an insurance company will recommend car owners to the corresponding 4S shops or repair shops for maintenance. In essence, both parties can reduce the cost of obtaining customers by reusing sales personnel with each other.

Second, a list of core players in each segment of the track

The core players in the automotive aftermarket include &mdash; &mdash;

1. Auto parts

① Brand manufacturers

Representative manufacturers include: Bosch, Denso Japan, Magna International, Continental Group, ZF, Aisin Seiki, Hyundai Mobius, Lear, Valeo, Faurecia, Andoto, Yazaki, Panasonic Automotive Systems, Sumitomo Electric, Mahler, Yanfeng, Toyota Textile, Jettaggart, ThyssenKrupp, BASF, Fuyao Glass, Weifang.

Because of the high initial investment cost and fierce competition of brand manufacturers, there are no star startups within the range of VC.

② Circulation channels

A. Main wearing parts: three heads and six arms, Kangzhong Auto Parts, Haomeite, and Kuaizhun Automobile.

Due to the high consumption frequency of wearing parts and strong SKU reuse among different car series, almost all wearing parts channel players cut into the supply chain in the self-operated B2B mode, and the upstream purchases from brand manufacturers and the downstream sells them to repair shops. At the same time, they operate their own logistics system and focus on the delivery of the last 1km.

In the retail store opening mode, Kangzhong Auto Parts mainly adopts the direct operation mode, and the three-headed, six-armed, good-beautiful and fast-accurate auto clothes mainly adopt the joining mode, each of which has its own advantages and disadvantages &mdash; &mdash; The service quality control of direct marketing mode is relatively standardized, but the disadvantage lies in the slow speed of opening stores and the long-term accumulation to show the scale effect of supply chain; The service quality control of the joining mode is not standard, and it is usually easy to receive customer complaints, but the advantage is that it can borrow private capital to start quickly and show the scale effect of the supply chain in a short time.

B. Main auto parts: Batulu, Kaisi, Chetongyun, Zhongchi Chefu and Haohao Auto Parts.

The whole vehicle parts are completely different from the wearing parts, and their extremely low frequency, numerous SKUs and non-reusable SKUs between different vehicles make all vehicle parts channel players use the inquiry and quotation system (including "Vin code &rarr; Auto parts SKU "database)+third-party trading platform (that is, Marketplace) mode cuts into the supply chain, and the upstream docking agents/dealers/retailers, downstream docking repair shops or 4S shops (some players indirectly obtain customer repair shops or 4S shops through cooperation with insurance companies), and there are both self-operated and third-party modes in logistics.

Since the inventory of the whole vehicle parts in the market circulation channel is often unstable after independence, in order to ensure the supply adequacy of the whole vehicle parts SKU and the timeliness of logistics delivery, all kinds of players in the whole vehicle parts channel have also begun to try to "control the goods" on the basis of the Marketplace model &mdash; &mdash; For example, Batulu’s self-built multi-level warehouse requires suppliers to put the goods in Batulu’s self-operated warehouse and requires warehouse goods to only receive deployment instructions from the platform.

C. All-category management: harmony with steam, rapid development and saving.

All-category channel players are essentially a combined version of two types of channel player modes, namely, wearing parts and whole vehicle parts, such as Heqi &mdash; &mdash; The business model of its wearing parts category is similar to Kangzhong, and the business model of its whole car parts category is similar to Batulu and Chetongyun.

The distribution channel of auto parts is a battleground for China auto aftermarket, essentially because this track has excellent scale effect, and the current situation of China auto parts field with scattered upstream and downstream and high gross profit margin in circulation is just an excellent soil to make use of scale effect &mdash; &mdash; The scale effect in the distribution channel of auto parts can make the enterprise reduce the purchasing cost, warehousing and logistics cost while the sales volume is increasing, and then the gross profit margin is increasing.

Take Auto Zone (American stock code: AZO), one of the four major auto parts chains in the United States, as an example. The changes of its sales and gross profit margin from fiscal year 1990 to fiscal year 2018 are shown in the following figure. It can be seen that in the time span of nearly 30 years, the sales of Auto Zone soared from US$ 670 million to US$ 11.22 billion, and its gross profit margin also increased from 38.1% to 53.2% (while the stock price rose more than 40 times). In essence, it is because the OEM brand and upstream centralized purchasing have brought about a sharp decline in procurement costs, and the logistics and warehousing costs under the DC (Distribution Center)-Hub-Store system are also declining.

2. Maintenance service

Representative companies include: Tuhu Car Maintenance, Auto Superman, Xiaoju Car Service, Diandian Car Maintenance, Master De, Chexiangjia, cluster car treasure, Changtu Automobile, Youyishou, New Focus (A-share listed company) and Xiaomuzhi (New Third Board listed company).

The basic mode of maintenance service players can be summarized as "upgraded repair shop", which provides car owners with beauty care, auto parts replacement or maintenance services, and sells third-party or OEM auto parts at the same time..Tuhu Car Maintenance is a typical example. At the beginning, it cut into the market with the tire category of wearing parts, providing online trading and offline installation services for car owners, and gradually became the first channel brand and maintenance service brand in the tire category. At present, Tuhu Car Maintenance has gradually expanded its own auto parts business (expanding engine oil, filters and other categories) and maintenance service business (expanding automobile beauty care, wearing parts maintenance and replacement, auto insurance sales and other services).

There are also various companies with unique entry points in the automobile aftermarket, such as Youchelian, Yunka and Zhengda Fortis, which cut into the maintenance of commercial vehicles, and Vin code &rarr; Mingjue Technology, which is cut into the database of automobile parts SKU, is cut into the automobile parts agent and forms a strategic cooperation with Manbang, and is cut into the music match &hellip; Due to the limitation of space, I won’t describe them here, but it can be seen that the current pattern of China’s automobile aftermarket is uncertain and the innovation vitality is still very abundant.

Third, the layout of giants

In recent years, giants in the fields of Internet, offline retail, used cars, logistics, insurance, automobile OEM, etc. have been frequently deployed in the automobile aftermarket (as shown in the following figure) &mdash; &mdash; Take Ali as an example. After trying the "car terminal" business in 2016, in 2018, Tmall once again established the "Xinkangzhong" alliance with Auto Superman and Kangzhong Auto Parts. Behind these three giants, they respectively represent the traffic of car owners, maintenance services and the huge potential of auto parts supply chain.

From the above table, we can feel that after the giants inject ① owner flow, ② warehousing & logistics capability, ③ financial capability (insurance & payment & credit) and ④ original auto parts supply chain and service capability into the automotive aftermarket, it is not only a blessing to this track, but also a challenge to the existing players in the track.

However, it should be noted that the core contradiction between supply and demand in China automotive aftermarket is not the inefficient matching of flow, but the low efficiency of auto parts supply chain and the low quality of maintenance service &mdash; &mdash; Therefore, for the giants who use traffic to bless the track (Ali, Tencent, JD.COM, Baidu, Didi, Guazi and Manbang), it is difficult to quickly end the war in the automobile aftermarket by using user subsidies in a short time. A new automobile aftermarket system with wide customers, good quality and high efficiency needs to be watered patiently.

First, the macro trend

The future development of China’s automotive aftermarket will be driven by the following five important forces &mdash; &mdash;

1. Demand side

① China’s automobile aftermarket will be in a growing trillion-dollar volume for a long time, and as more and more cars leave the 4S shop maintenance period, more and more car owners will choose the independent aftermarket in the future;

(2) The increasing GDP per capita in China and the increasing professionalism of citizens in automobile knowledge will create the demand for high-quality chain service organizations, high-quality chain auto parts channels and domestic brands of high-quality auto parts;

2. Supply side

(1) Thanks to the long-term experience of OEM for European and American international brands, the supply chain system of China auto parts manufacturers is very mature, and they can provide auto parts with almost the same quality and higher cost performance as European and American international brands in quite a few categories, so it is possible to produce high-quality domestic brands of auto parts;

② The distribution channels of auto parts in China’s post-independence market system are currently in a large and scattered pattern, and the market share of Top-3 channel players is less than 1%; However, the auto parts track has the characteristics of positive scale effect, and several big head companies will be produced in the future.

With reference to the auto parts market in the United States, the overall market share of the four auto parts chains, Auto Zone, Advance Auto Parts, O’Reilly and NAPA, is more than 30% and is still rising. Due to the consistency of the supply chain attributes of auto parts, China auto parts channel companies will accelerate the appearance of scale effect when the infrastructure such as Internet, AI and logistics are mature.

(3) The development of automobile control unit networking, AR, Internet and other technologies will help repair shops greatly improve service quality and reduce service costs.

Second, 13 ways to upgrade the post-steam industry

Any industry, its direction of creating value mainly includes three kinds:

(1) better quality:That is, the products and services provided by the industry make consumers experience better;

② Higher efficiency:That is, the industry consumes less resources to deliver each unit of products and services, among which the core resources are money (cost) and time &mdash; &mdash; In the steady state (that is, in the state of non-burning money), the lower pricing limit of products and services provided by the industry to consumers is determined by the consumed cost, and the lower convenience limit is determined by the consumed time;

(3) get more customers:That is, the products and services provided by the industry can reach more consumers.

P.S. The value creation direction of an industry is also the lifelong struggle direction of all enterprises in the industry &mdash; &mdash; Whether the enterprise is in the production link, distribution link or the final retail service link.

Based on the five macro forces on the demand side and supply side of China automobile aftermarket, Combined with the players after China automobile, the four major auto parts chains in the United States (Auto Zone, Advance Auto Parts, O’Reilly, NAPA)& maintenance service unicorn (Monro Muffler Brake, Valvoline), the world retail giants (WalMart, Costco, 7-11), (4) observation of companies such as Amazon Web Service (WeWork) and venture capital enterprise (looking for steel net and intelligent cloth interconnection) focuses on the three value creation directions of "getting more customers, better quality and higher efficiency".

The author thinks that players in auto parts and maintenance service tracks can use the following 13 methods to build long-term value and become unicorns in the automotive aftermarket &mdash; &mdash;The company’s value and growth rate depend on the diversity of the following 13 methods and the speed of promotion. The more methods used and the faster the promotion, the greater the company’s value and the faster the growth rate..

1. Auto parts

① Business flow

< the first move > set list:　

Intensive expansion of the service area of circulation channels through direct marketing/joining/merger/joint venture (joint venture through Marketplace mode) and other ways, so as to intensively expand the order volume, and then reduce the purchase cost and enhance the quality control ability through the way of < centralized collection and unified procurement > or < self-operated OEM brand >;

< 2nd move > membership system:

Establish a membership system to reduce the circulation uncertainty of the whole supply chain by locking the purchase behavior of auto parts of car owners or repair shops in advance, and then reduce the inventory backlog cost and labor cost under no operation state caused by circulation uncertainty;

< 3rd move > "Vin code &rarr; Auto parts SKU "database:

Establish a database of mapping relationship between vehicle Vin code and auto parts SKU, and support 4S shops/repair shops, distribution channels and brand manufacturers to interact in various ways, such as text/picture/voice, which greatly reduces communication costs;

② Logistics

< 4 > logistics infrastructure:

Establish central warehouse, city warehouse, pre-warehouse (store) system and logistics billing algorithm to greatly reduce logistics costs in the case of intensive orders (depending on the use progress of various methods in business flow);

③ Production

< 5th move > hardware upgrade:

Under the basic conditions of highly mature auto parts supply chain in China, < introduce advanced hardware equipment of world top brands > or < self-developed hardware equipment >, thus reducing the production cost of the factory and improving the delivery quality of the factory;

< No.6 > Software upgrade:

Open ERP system with downstream channels and upstream raw material suppliers, and do capacity optimization based on data (sales order information/raw material supply information/factory capacity information) and AI algorithm;

④ Finance

< No.7 > vertical supply chain finance:

Due to the inconsistency between upstream and downstream accounting periods in the auto parts industry chain, data-driven supply chain financial services can be provided for brand manufacturers, distribution channels, repair shops /4S stores (refer to steel B2B e-commerce players looking for steel nets);

⑤ Internal operation of enterprises

< trick 8 > SaaS:

For factories, distribution channels, repair shops /4S stores, develop professional SaaS systems suitable for auto parts industry, so as to improve the operating efficiency of each unit of the industrial chain (including invoicing, ERM, IM, manpower, finance, etc.).

2. Maintenance service

① Business flow

< trick 9 > bind the insurance company:

Deep binding with insurance companies through cooperation agreements/cross-shareholding, etc., the two sides share customer resources with each other and jointly reduce the cost of obtaining customers;

< 10th trick > membership system:

Establish 2C membership system, reduce the uncertainty of service demand forecast by locking the maintenance consumption behavior of car owners in advance, and then reduce the inventory backlog cost and labor cost under the condition of no operation caused by the uncertainty of demand forecast;

② service

< 11th move > Senior technicians share the platform:

Because experienced technicians in a region are scarce resources, and the cost of hiring such senior technicians in a single repair shop is too high (the frequency of difficult problems encountered by a single repair shop is relatively small), the shared platform for senior technicians can minimize the labor cost of repair shops and increase the personal income of senior technicians at the same time;

< 12th move > Maintenance experience sharing platform:

China’s Ministry of Communications conducts certification examination for maintenance technicians in repair shops every year, but there is no strict high-standard system for qualification examination as a whole, so most technicians still need to improve their maintenance level through "personal experience" and "indirect reading of master’s work notes".

Therefore, establishing a maintenance experience sharing platform to support technicians to find corresponding solutions through text/picture/voice when encountering problems can greatly improve the maintenance quality and reduce the maintenance cost (reducing the cost of returning goods and training due to misjudgment, etc.);

< 13th move > Remote maintenance and diagnosis platform based on networked sensors;

At present, all the control units (such as engine and gearbox) in the car have been digitized and networked, and automobile brand manufacturers have established a perfect data diagnosis and maintenance guide system based on this. In the past, this system was only open to 4S shops, but now it has been gradually introduced into the independent market.

Therefore, based on this technology, a remote maintenance and diagnosis platform can be established, which can automatically give early warning signals in the process of automobile driving and then guide the owner to adjust his driving habits or carry out lightweight maintenance. After an automobile accident, the platform can automatically send orders to the best repair shop nearby and support experienced technicians and experts to interact with ordinary technicians in the first-line repair shop in real time through AR equipment, thus greatly improving the maintenance quality of the repair shop and reducing the maintenance cost (reducing the labor cost of senior technicians).

It should be noted that &mdash; &mdash;

① There is no fixed application order for these 13 methods.For example, a company can first be an OEM brand foundry, and then use the advantages of supply chain to intensively open auto parts chain stores; You can also start a chain store of auto parts intensively first, and then make an OEM brand after you have a scale advantage.

② These 13 methods can be completely used by one company, and can also be jointly used by more than one downstream cooperative relationship or joint venture of several enterprises.For example, logistics infrastructure, an auto parts distributor can build its own logistics infrastructure, use the logistics infrastructure provided by a third party, or build its own logistics infrastructure for some businesses and use a third party for some businesses.

③　The value of the company and the speed of its growth depend on the diversity of the company’s use of 13 methods and the speed of promotion.But it doesn’t mean that companies need to use various methods at the same time in the initial stage. It is suggested that start-ups focus on one thing in the early stage to achieve the ultimate. The so-called "it is better to break one finger than to hurt its ten fingers".

How to choose a company needs to carefully consider its own business resources, team resources and market competition environment in specific regions.

Due to the limited space, this paper only presents the valuation status of "auto parts circulation channel", and the valuation system of auto parts manufacturers and maintenance services can be used as a similar reference.

The following table shows the core business data and valuation data of the four major auto parts chain companies in the United States &mdash; &mdash; Since the main business of Genuine Parts Company includes NAPA, industrial products and office supplies, it is not easy to separate them, so Auto Zone, Advance Auto Parts and O’Reilly are the best three valuation benchmarking companies for auto parts circulation track.

According to the calculation of 2 times P/S, if the market share of an auto parts channel company in China exceeds 1%, the company can become a unicorn with a value of 2.2 billion US dollars (780 billion RMB ×1%×2×1 US dollars /7.07 RMB = 2.2 billion US dollars); If an auto parts channel company is worth US$ 1 billion, its annual revenue only needs to reach RMB 3.5 billion (US$ 1 billion /2×7.07 RMB/US$ 1) and its market share is 4.5&permil; (3.5 billion RMB/750 billion RMB).

For auto parts distribution channel start-ups who are interested in cooperating with VC,We can consider taking [becoming a unicorn with a billion dollars in eight years] as the goal, so as to reverse the annual opening plan and store revenue growth plan in the first to eighth years, and accordingly design what kind of commodity procurement system, warehousing and logistics system and store operation system should be built to achieve this [final goal], and then design what kind of team needs to be formed in order to realize this system.&mdash; &mdash; Although the plan can’t keep up with the changes, and there are many uncertainties in the future business progress, in most cases, "if you plan ahead, you will be abolished."

P.S. The valuation calculation here is only used as a reference for large numbers. In fact, the valuation should be comprehensively considered in combination with the specific fundamental status quo, revenue/gross profit/net profit growth rate and competition links of the enterprise at that time.

　The above is the analysis of the present situation and future of China automobile aftermarket according to the top-down method &mdash; &mdash; After 10 years, there will be many unicorns in the aftermarket. I look forward to your contribution here!

[Author of Titanium Media: This article comes from WeChat WeChat official account "Xianfeng Chuangchuang" (ID:xianfengk2vc) by Zhang Runtao. 】

　　350 kilometers per hour! China’s high-speed rail conducts "up-to-speed" test

　　What signals did Taobao release in the "first case" of winning the fake sale?

　　International long-distance phone tariffs will continue to decrease

　　Our country set up an "aircraft carrier" for clinical research on major diseases

　　****

　　What were the major events of the past week? Which ones are worth paying attention to? Which ones are relevant to you? Please see the review of the major events of the week.

　　[Fuxing] 350 kilometers per hour! The reporter takes you to experience the "up-speed" test of China’s high-speed rail

　　At 8:38 on the 27th, the "Fuxing", a standard Chinese EMU, pulled out of the Beijing South Railway Station and accelerated in an instant. After more than four hours, it made a round-trip between Beijing and Xuzhou on the Beijing-Shanghai high-speed rail. Along the way, the "Fuxing" has a top speed of 352 kilometers per hour. Six years later, China’s high-speed rail has ushered in this "up-to-speed" test, heralding the return of China’s 350-kilometer high-speed rail era.

　　[straight-A student choir] Tsinghua super "straight-A student choir" sings and cries countless netizens, with an average age of over 72 years old

　　"I love you, China. I love you, China, and I want to dedicate my beautiful youth to you…" A group of elderly people with an average age of 72.3 years, with tears in their eyes, sang the popular "I Love You China" on the stage of CCTV. Once the program was broadcast, it attracted countless netizens to tears.

　　[Sports] Sun Yang and Xu Jiayu pick gold at the World Championships: be the protagonists together and carry the banner together

　　Sun Yang and Xu Jiayu made breakthroughs at the FINA Swimming World Championships on the 25th, one filling a gap in the individual honor book with the men’s 200m freestyle gold medal, and the other giving Chinese athletes a place on the top podium of the men’s backstroke world championships. The pool at the Danube Swimming Pool saw three people rewrite the world record four times that day, including the British man Peeti in the men’s 50m breaststroke breaking twice in one day.

　　"Discovery" collected a large number of cold spring organisms in the South China Sea

　　On the 25th, the "Discovery" remote-controlled unmanned submersible carried by our country’s new generation of ocean-going comprehensive scientific research vessel "Science" brought back a large number of biological samples from a cold spring area in the South China Sea, including more than 100 biological samples such as submersible armor shrimp, mussels and Alvin shrimp, and took a large number of submarine high-resolution video data.

　　[Ecology] Northwest Ecological Barrier Qilian Mountains: The "Strictest in History" Accountability Storm Brings "Green Revolution"

　　Over the past few days, the Central Office and the State Office have issued a notice on the ecological environment of the Qilian Mountains National Nature Reserve in Gansu Province, which has attracted widespread attention from the society. Up to now, hundreds of people, including three deputy provincial cadres in Gansu Province, have been held accountable for the ecological damage of the Qilian Mountains. This environmental accountability storm, known as the "strictest in history", has also triggered profound reflection among the cadres and people involved.

　　[Science and technology] our country’s space quantum communication technology has made a breakthrough: laying a solid technical foundation for building a quantum constellation

　　Recently, a research team composed of Professor Pan Jianwei of the University of Science and Technology of China and colleagues Peng Chengzhi and Zhang Qiang has successfully realized daytime long-distance (53km) free space quantum key distribution for the first time in the world, and effectively verified the feasibility of future satellite-to-ground and inter-satellite quantum communication networks based on quantum constellations in terms of channel loss and noise level through ground-based experiments. The results were recently published in the international authoritative academic journal Nature Photonics.

　　[Roaming charges] Cancel long-distance roaming charges from September 1

　　Zhang Feng, chief engineer of MIIT, said at the press conference of the State Council Information Office on the 25th that our country will gradually reduce the tariffs for international long-distance calls in more directions. More characteristic broadband products will be launched for industrial parks, "innovation and innovation" enterprises, and will speed up the cancellation of domestic long-distance roaming charges for mobile phones.

　　[Cold Observation] Who made the delivery guy "run all the way"?

　　Worried that the food delivery truck would be towed away, he knelt down and begged for mercy in the street in a hurry; he sent multiple orders in the high temperature, and fainted from heatstroke during the delivery; he was worried that the delivery would be timed out, so he stomped his feet and cried in a hurry… "Kneel", "dizzy" and "cry", reflecting the hardships of the group life of the delivery brother, which made many netizens leave messages "so distressed".

　　[Flood control] The No. 1 flood this year occurred in the Yellow River

　　The reporter learned from the Yellow River Flood Control and Drought Relief Headquarters that at 1:06 on July 27, the Yellow River experienced the No. 1 flood of 2017, with a peak flow rate of 6010 cubic meters per second at the Longmen Hydrological Station located in the middle reaches of the Yellow River.

　　[High temperature] High temperature orange warning: local maximum temperature in 13 provinces exceeds 40 ° C

　　According to the official website of the Central Meteorological Observatory, the Central Meteorological Observatory continued to issue a high temperature orange warning at 6:00 on July 23: During the day on July 23, there were high temperatures above 35 degrees Celsius in the eastern part of the northwest region, Huanghuai, the eastern part of the Sichuan Basin, Jianghan, Jianghuai, Jiangnan, and northern South China.

　　[Medical and Health] Our country has established an "aircraft carrier" for clinical research on major diseases

　　32 national clinical research centers have been built around 11 disease fields such as cardiovascular diseases, malignant tumors, and respiratory diseases. Relying on 30 Tier 1 hospitals with the strongest strength and highest level in the field of disease prevention and control, more than 2,100 medical institutions at all levels in about 260 prefecture-level cities have been combined to form a high-level clinical research platform and collaborative innovation "aircraft carrier formation"…

　　16 shared sleeping cabin business sites in Beijing have stopped operating, and the operators have been interviewed

　　The appearance of "shared sleep capsules" in Zhongguancun, Beijing, has attracted attention. The reporter learned from the Beijing police that the public security organs attach great importance to this. After investigation, it was found that the "shared sleep capsules" are "sleeping space" space capsules developed by a company in Beijing. These space capsules can be used without registering identity information, and are easy to be used by criminals and criminals to hide. The space capsules are closed and have small internal space. After a fire, they cannot be extinguished in time to escape, and there are security and fire hazards.

　　[E-commerce anti-counterfeiting] What signals did Taobao release in the "first case" of winning the sale of counterfeit merchants?

　　According to the information obtained by the Fengxian District People’s Court and Alibaba Group, this is the first case in the country in which an e-commerce platform has prosecuted a fake online store. The industry believes that the judgment of this case will form a deterrent to such illegal acts, play a positive role in mobilizing social co-governance, maintaining fair competition, and improving the consumption environment. It also recommends further improving legislation and strengthening the punitive compensation system to increase the illegal cost of fake sales.

　　Recently, China began to deploy COVID-19 vaccine to strengthen immunization in sequence. So, is sequential vaccination "mixing" different brands of vaccines? In fact, sequential vaccination emphasizes vaccination with different technical routes at intervals. Then why sequential vaccination? Is there a similar deployment abroad?

　　Why sequential inoculation?

　　Sequential inoculation refers to interval inoculation (alternate inoculation) of vaccines with different technical routes. According to Shao Yiming, a member of the expert group of the vaccine research and development special class of the joint prevention and control mechanism in the State Council, China, at the press conference of the joint prevention and control mechanism on the 19th, sequential immunization is often used for viruses with strong variability and difficult to deal with.

　　Wang Huaqing, chief expert of immunization program of China CDC, said that some countries in America, Europe and Southeast Asia have started to implement sequential immunization.

　　The European Medicines Agency and the European Center for Disease Control and Prevention issued a statement in December, 2021, saying that many studies showed that mixed inoculation ("mixed inoculation") of adenovirus vector vaccine and mRNA (messenger RNA) vaccine could "produce a better antibody level" and "produce a better T-cell immune response than vaccines using the same technology". T cells are one of the defenses against diseases in human body.

　　The statement said that "mixed vaccination" can "provide richer vaccination options, especially when a vaccine cannot be vaccinated for some reason, which can reduce the impact on vaccine promotion".

　　Shao Yiming said that there are two main purposes to adopt sequential immunization: one is that different vaccines can complement each other, and the other is that different personal constitutions may have more side effects on a certain type of vaccine, and vaccination with different technical routes can avoid side effects.

　　Temporary guide to "mixed fighting"

　　Based on the existing research data, the World Health Organization issued the interim guidelines for "mixed vaccination" in COVID-19 in December 2021. This guide is based on the recommendations made by the WHO Strategic Advisory Expert Group and is applicable to all COVID-19 vaccines on the WHO emergency use list. The guidelines suggest that if the first dose is a viral vector vaccine, whether the second dose or the booster dose can be vaccinated with mRNA vaccine; or vice versa, Dallas to the auditorium If inactivated vaccine is inoculated at first, viral vector vaccine or mRNA vaccine can be inoculated later.

　　Up to now, the vaccines that have entered the WHO emergency list include: AstraZeneca vaccine in Britain, Johnson & Johnson vaccine, Mardner vaccine and Pfizer vaccine in the United States, Sinopharm vaccine and Kexing vaccine in China, Covaxin vaccine and Covovax vaccine in India, and Novavax vaccine in the United States. Among them, Kexing, Sinopharm and Covaxin are inactivated vaccines, Johnson & Johnson and AstraZeneca are adenovirus vector vaccines, Mardner and Pfizer are mRNA vaccines, and Novavax vaccine and CoVAX are recombinant protein vaccines.

　　According to the provisional guidelines, the existing research mainly involves the influence of "mixed beating" on human immunity. It is still the current standard practice to choose the same vaccine as the first shot when inoculating the second and third shots, but with the deepening of research, WHO will re-evaluate the advantages and risks of "mixed shots". With the release of more research data, it is not excluded to adjust the "mixed play" guide.

　　Many countries approve "mixed fighting"

　　On October 20, 2021, the US Food and Drug Administration revised the authorization for emergency use of vaccines in COVID-19, allowing vaccinators to choose vaccine booster needles with different brands than those previously vaccinated. Peter Marks, director of the Center for Biological Products Evaluation and Research of the US Drug Administration, said that the decision to allow "mixed injections" to strengthen needles aims to meet the needs of the people as much as possible.

　　After studying the test results of Spanish and British mixed vaccination with COVID-19 vaccine, the Canadian National Advisory Committee on Immunization announced new regulations in June 2021, allowing mixed vaccination with COVID-19 vaccine, so as to further accelerate the vaccination progress. The first dose of AstraZeneca vaccine, the second dose can choose the same vaccine, Pfizer or Mardner vaccine.

　　South Korea, Britain and other countries have started clinical trials on sequential vaccination of COVID-19 vaccine. In May 2021, the disease control department of Korea started the clinical trial of sequential vaccination. The first batch of subjects were about 500 people who had been vaccinated with one dose of AstraZeneca vaccine, and the second dose was vaccinated with other COVID-19 vaccines such as Pfizer. The results showed that people who were inoculated with AstraZeneca and Pfizer vaccine in sequence would increase the neutralizing antibody level by 6 times compared with those who were vaccinated with two doses of AstraZeneca vaccine.

　　In February, 2021, Oxford University in the United Kingdom launched a clinical trial of sequential vaccination of COVID-19 vaccine. AstraZeneca vaccine and Pfizer vaccine were mixed in the first phase clinical trial, and Mardner vaccine and Novavax vaccine were used in the second phase trial in April.

　　The results showed that the antibody level of volunteers who were vaccinated with Pfizer vaccine and then AstraZeneca vaccine was about 5 times higher than that of volunteers who were vaccinated with two doses of AstraZeneca vaccine, and the antibody level of volunteers who were vaccinated with AstraZeneca vaccine and then vaccinated with Pfizer vaccine was 9 times higher than that of those who were vaccinated with two doses of AstraZeneca vaccine. Vaccination with AstraZeneca vaccine first and then with Mardner or Novavax vaccine will produce higher antibody level than two doses of AstraZeneca vaccine.

　　According to Xinhua News Agency

　　China news agency, Tokyo, July 26 th, "Let’s let it go about the Rio Olympics and turn it over." Walked down from the men’s 67kg podium, turned his head to one side, waved his left hand and said.

　　On the evening of July 25th, Beijing time, in the men’s weightlifting 67kg class of Tokyo Olympic Games, China’s Chen Lijun won the championship with 145kg in snatch, 187kg in clean and jerk and 332kg in total score, breaking the Olympic records of clean and jerk and total score, and also won the sixth gold medal for the China sports delegation. The picture shows Li Lijun taking off his mask at the award ceremony. China News Service reporter Han Haidan photo

　　This is a night belonging to the imperial army, and the champion needs to digest. That sad night in Rio five years ago also needs to be digested.

　　That sad night was August 8, 2016, the second competition day after the opening of the Rio Olympic Games. After two consecutive snatch failures, the Patent Army withdrew from the men’s weightlifting 62kg gold medal competition.

　　This is an unexpected result. Before the Rio Olympic Games, in the 2015 World Championships in Houston, the Patent Army broke the world record of 62kg and won the championship.

　　The Chenli Army, which played in Rio Olympic Games with a halo, was originally regarded as one of the most stable gold rush points of China weightlifting team. No one expected that the accident would happen.

　　During the warm-up session before the game, Li Lijun suffered from cramps in his legs. In the words of coach Yu Jie, his legs were "as hard as stones". After a simple massage, Chen Lijun felt a little relaxed in his legs, so he tried to snatch 143 kilograms. "But as soon as I grab the barbell, my legs get hard again. I really can’t help it." Chen Lijun said helplessly after the game.

　　Facing the camera, the strong weightlifting man’s eyes were red and he choked and said several "sorry".

　　After retiring from Rio, the Patent Army entered a new round of preparations for the Olympic Games, but it is obviously more difficult to get back what it is about to get than simply winning gold.

　　Returning to the World University Weightlifting Championship, winning the national championship and winning the national games, the Chenli Army slowly regained its mood. "Winning the Tokyo Olympics is proud." One year later, the sorrow of Rio is still in the heart of the patent army.

　　In July 2018, the international weightlifting Federation adjusted the level of weightlifting events, and the 62 kg class was adjusted to the 67 kg class. After the weight gain, the Li Lijun still performed steadily.

　　At the 2018 World Weightlifting Championships, the patent army successfully won the championship by breaking the men’s 67 kg world record with 332 kg. "The next step is to prepare for a new level wholeheartedly. I hope to have a dream in Tokyo!" Every time Chen Lijun is interviewed, it seems that he can’t get away from the topic of Tokyo’s dream.

　　In the men’s 67kg class competition of the World Weightlifting Championships in 2019, the Patent Army made a further breakthrough and won the championship with 337kg. He would not have thought that the 187kg completed in the clean and jerk had laid a great foundation for his dream trip.

　　In 2020, under the epidemic, the Tokyo Olympic Games was forced to be postponed for one year. In October, the Chenli Army suffered a hand injury and needed surgery. "It was a big blow. I never thought I would have surgery in my career." Yan Lijun said.

　　Fortunately, the injured troops did not give up. Five months later, he came back from injury. In the Asian Championships in Tashkent in April, the Chenli Army won the championship with the clean and jerk and the total score. The excellent performance of the "mock exam" of the Tokyo Olympic Games has completely let the troops out of the scruples of injuries.

　　Standing on the stage of dreams, the patent army failed to snatch the second and third consecutive attempts, which had to make people’s thoughts travel back to Rio five years ago. You know, in the snatch of 145 kilograms, this achievement was only tied for fourth place among 10 players, 6 kilograms behind Colombian Mosquera.

　　In the clean and jerk, Mosquera is still strong, with a successful attempt of 180kg, which means that the Chenli Army has to put all its eggs in one basket to lift 187kg in the last two attempts, which is 12kg higher than the previous attempt.

　　Quickly walked onto the stage, grabbed the barbell, and struggled to lift it. Li Lijun steadily lifted 187 kilograms. This is the weight that the Patent Army has never lifted in the competition after the 2019 World Championships. With a breath from Rio to Tokyo, he made a miracle in deus ex from the corner.

　　"Sometimes I think of the bitterness of this road and feel a little like crying, but I will pass if I think about winning the championship later." Chen Lijun, who just stepped off the podium, said excitedly.

　　But obviously, the taste of waiting for five years is not so easy to digest. Half an hour later, when talking about this topic again in the press conference hall, Li Lijun choked and said, "It’s really not easy to walk all the way. I have been trying to win the championship for years. My opponent is very strong in this competition, but I am stronger!"

　　Five years later, another night of tears, the story of the dream of Kouli Army came to a successful conclusion in a ups and downs way, which is also the epitome of the five-year preparations for the Olympic Games. (End)

1905 movie network news As of December 23rd, 2016, the box office of mainland movies exceeded 44.1 billion yuan, and it took 358 days to surpass the total box office of 44.069 billion yuan last year, which is far from the rate of exceeding the box office of 2014 in just over nine months in 2015. This year’s box office growth rate will be lower than 25% for the first time in 13 years. According to the current overall box office trend, the box office growth rate in 2016 is likely to be less than 3%, which is also the slowest year of box office growth in China in the past 17 years.

However, looking back on the film market in 2016, there are still many things worthy of recognition: the box office performance of Xingye reached 3.389 billion yuan, which became the first film in China to break through the 3 billion yuan mark and also set a new record in China film history. This year, single-day, single-week and single-month box office also created the best results in history. In addition, it is worth mentioning that among the films released this year, as many as 84 films have exceeded 100 million yuan at the box office.

Single-chip, single-week, single-month, record-breaking. In February, 6.8 billion box office ranked first in the whole year.

In recent years, China’s film industry has developed rapidly, and the box office has grown from less than 1 billion in 2002 to more than 44 billion today. In just 14 years, the box office has increased 45 times, ranking second in the global film market. In 2010, the growth rate of box office in mainland China reached 64%, and the growth rate of box office in 2009 and 2015 also remained above 40%.

In 2016, after the record-breaking rapid development in the first quarter, the growth rate of box office in China suddenly slowed down, and the box office output declined month by month, which once caused the "panic" of filmmakers. But fortunately, the popular schedule still performed well, especially the summer file saved a lot of decline. In addition, the single-chip "turning the tide" brought the eleventh file and the New Year file. Finally, when there were eight days left in 2016, the box office successfully broke through the 44.1 billion yuan mark, which made it difficult to surpass the total box office in 2015. Although the industry predicted that the annual box office of 60 billion yuan could not be realized at the beginning of the year, this year has also become the first year in 14 years that the growth rate of box office in mainland China has dropped to single digits, but looking back at the whole year, there are still frequent highlights.

Top three movie box office rankings in 2016

This year’s single-film, single-day, single-week and single-month box office have all set new records in film history, which makes people clap their hands. Among them, The Mermaid, directed by Stephen Chow, earned 280 million yuan on the opening day, and reached 310 million yuan on Valentine’s Day on February 14, and surpassed 2.439 billion yuan in 12 days, making it the top box office champion in the mainland film history. "Mermaid" therefore announced a three-month extension, and finally ended with 3.389 billion yuan, becoming the first film in China to rank among the 3 billion clubs.

With The Mermaid and the escort of the Troika released on the same day at the beginning of this year, the February box office with only 29 days was brought to a high of 688,500 yuan, exceeding the highest monthly box office of 5.5 billion yuan set in July last year, successfully refreshing the single-month box office record in China and becoming the first month in the history of mainland film to break 6 billion yuan. February this year is a record year, and from February 8 to February 14,Create a new single-week box office record with a box office output of 3.63 billion yuan.The original box office of 1.78 billion yuan (from July 13 to 19, 2015) doubled. The box office reached a new high that day, with 646 million, 603 million and 526 million box offices on February 8, February 14 and February 9, respectively, ranking among the top three in the single-day box office of the mainland film history.

Five domestic films have grossed more than 1 billion. Who will break the 3.3 billion myth of The Mermaid?

In 2016, the movie "The Mermaid" and "He" won the first, second and third place at the box office in mainland China this year with 3.38 billion yuan, 1.53 billion yuan and 1.47 billion yuan respectively. Mermaid, Monkey King Thrice Defeats the Skeleton Demon on a Journey to the West, operation mekong, storm riders of Macau and five domestic films are among the 1 billion yuan clubs, leading the box office charts of Chinese films this year.

Up to now, a total of 84 Chinese and foreign films released in the mainland have exceeded 100 million at the box office this year, of which 41 Chinese films have exceeded 100 million. However, it just premiered on December 23, and no matter what the word of mouth is, I believe there is no suspense in the box office of the two films exceeding 100 million.

This year, The Mermaid’s box office achievement of 3.3 billion yuan has reached the dust. No matter Xiaogang Feng’s I Can’t Pan Jinlian, or the big IP Tomb Notes, or World of Warcraft and other Hollywood blockbusters, it has failed to shake Stephen Chow’s position. As of 15: 00 on December 23rd, Zhang Yimou’s highly anticipated new work "The Great Wall" had less than 700 million box office, and it was hopeless to surpass The Mermaid.

Then, who will break this record, can only wait until next year, especially on the first day of 2017, nine films will be released together, directed by Tsui Hark, directed by Wang Baoqiang and starring Jackie Chan, and many Hollywood sequel to the movie, etc., will all launch a powerful impact on the single-chip box office record of 3.3 billion.

Since the beginning of this year, the municipal taxation department has taken the opportunity of institutional reform to tailor-made "targeted" service measures for various enterprises, further helping generate, a private economy, to create vitality, to promote the gradual transformation and upgrading of established state-owned enterprises, and to effectively serve enterprises in a new journey of high-quality development. Today and tomorrow, Xiaoyan will take you to know what the tax authorities in our city have done to serve enterprises. Today, let’s take a look at how the municipal tax department serves the development of private enterprises.

Inter-departmental cooperation to support the innovation and development of private enterprises

Private enterprises that support half of China’s economy have contributed more than 70% of technological innovation. In order to make the innovation source of private economy fully flow in, the enjoyment of high-tech tax preferential policies is undoubtedly one of the effective tools.

As the first private enterprise in Shanghai with the qualification to operate a chain Internet cafe, Shanghai Wangyu Information Technology Co., Ltd. revealed to Songjiang District Taxation Bureau the problems encountered by the enterprise in the investigation: the enterprise has a service fee of 38.3443 million yuan for joining the management system, and there are different opinions between the enterprise and the high-tech certification office on whether this income belongs to high-tech products.

The person in charge said: Whether it can be recognized as a high-tech enterprise and enjoy the preferential corporate income tax rate is particularly important for us technological innovation enterprises. If it cannot be identified, it will directly affect the high-tech qualification of our enterprise and the enjoyment of preferential policies.

To this end, the research team of Songjiang District Taxation Bureau immediately reported the problem to the Municipal Taxation Bureau, and the Municipal Bureau cooperated with other departments, actively communicated and negotiated with the Municipal High-tech Certification Office, and decided to hold a special "inquiry meeting" for enterprises to solve the problem. After the research and discussion of experts in the high-tech accreditation industry, the Municipal High-tech Accreditation Office finally recognized the enterprise’s statement and determined that the income can be included in the income of high-tech products. The relevant person in charge of the enterprise said that after successfully solving this problem, enterprises can enjoy a total tax reduction of nearly 5 million yuan in 2016 and 2017.

In addition to policy judgment, how to obtain the qualification certificate of high-tech enterprises faster is also the focus of enterprises’ attention. Many "dual-innovation" enterprises have reflected the "blocking point" problem encountered in the process of high-tech application: the application materials for high-tech certification contain some tax-related information, but the tax-related information is more professional and difficult to fill in. If the preparation is not in place, it is likely to lead to the failure of the "high-tech" application in the current year and delay the time for policy enjoyment.

In view of the problems raised by enterprises, Yangpu District Taxation Bureau and Yangpu District Science and Technology Commission jointly optimized the audit process of high-tech enterprises. The original "serial audit" mode of "science and technology commission first, then tax" was changed to the "parallel audit" mode carried out by two departments simultaneously. After receiving the list of enterprises applying, the district science and technology commission shared it as soon as possible. At the same time, the tax department began to "pre-examine" the tax-related materials, actively reminded and publicized the relevant policies and regulations, and gave enterprises sufficient time to make corrections. Through pre-counseling, the pass rate of enterprises applying for "high-tech" for the first time will be greatly improved, which will add impetus to enterprises’ accelerating the transformation of technological achievements and smoothly entering the fast lane of innovation and development.

Serving "going out" and escorting the overseas development of private enterprises

At present, "going out" is no longer the "patent" of multinational companies and large state-owned enterprises, and many private enterprises, even small and medium-sized enterprises, have begun to take advantage of the wind to go abroad. Recently, the Qingpu District Taxation Bureau conducted a special investigation on this kind of enterprises. Through field visits to a number of high-tech start-up private enterprises such as Huace Navigation and Universal Navigation located in the Beidou Industrial Park of Xihongqiao, it was found that these enterprises have strong technical research and development and market development capabilities, but they often lack sufficient understanding and adaptability to cross-border tax-related policies in the process of "going out to sea".

In order to fill this "short board" and help enterprises avoid potential tax-related risks, researchers have launched a series of classified "targeted" service measures, so that policy guidance can accurately match the pace of enterprise development, including: compiling "Guidelines for Tax Services and Management of Going Out Enterprises", and "peer-to-peer" directional push to 127 enterprises in the area to put a security lock on their cross-border business activities; Specially implement "country-by-country" guidance for small and medium-sized enterprises with high risks due to lack of experience, and invite a group of enterprises with manufacturing projects in Southeast Asian countries to open special exchange meetings; For enterprises that intend to "go out", they should actively communicate with Xihongqiao Development Zone, improve and optimize the service framework systematically through the combination of "regional promotion" and "personalized counseling", and give long-term tax support from the source.

The person in charge of the enterprise revealed that the international environment is complex and changeable, and the unfamiliar tax system and collection and management model are severe challenges. Thanks to the escort of the tax department, it paved the way for the overseas development of the "going out" enterprises in the park.

The relevant person in charge of the Qingpu District Taxation Bureau said: When the comprehensive cross-border tax-related services of the taxation department are combined with the technological advantages of the enterprises’ own products, it not only stimulates the international competitiveness of’ going out’ enterprises, but also sets up a good demonstration effect in the region, so that more enterprises dare to invest in the sea. In just one year, the number of enterprises in the region investing in overseas targets has increased by more than 50, with an additional investment of 2.55 billion yuan.

Pudong New Area is the forerunner of Shanghai’s opening to the outside world and plays an extremely important role in Shanghai’s "going out" strategic planning. Zhongman Oil and Gas Group Co., Ltd. is a private oil service company registered in Pudong. Enterprises seized the opportunity of the "Belt and Road Initiative" and cooperated with Gazprom and Petronas Malaysia to jointly develop drilling business in Middle East countries. By the end of 2017, the amount of foreign investment reached 1.228 billion, and the income from overseas business accounted for more than 80% of the total income.

Faced with such a huge volume, the investigators of Pudong New Area Taxation Bureau tailored the service plan "one-on-one". In order to safeguard the legitimate rights and interests of enterprises and strive for the maximization of tax-related rights and interests, the regional bureau took the initiative to come to the door, introduced the international tax agreements and international common practices to enterprises in detail, advised enterprises to issue the Resident Identity Certificate in time, and helped them successfully complete the credit for the 102 million yuan tax paid in Iraq, effectively serving the "going out" enterprises to achieve stability and prosperity.

After reading today’s content, are you satisfied with the practice of the tax department? Tomorrow, Xiaoyan will show you how the tax department supports the development of large enterprises and traditional state-owned enterprises. See you tomorrow!

(The original title is "How to pay the service fee of 38.34 million Internet cafes? The tax authorities do this ")

In winter,Everyone’s table is bound to get around.Hot pot.Many people want to eat and even can’t live without hot pot.Is eating hot pot healthy?How to eat hot pot scientifically is healthier?

Compared with frying and roasting at high temperature

Hot pot is really healthier.

Compared with frying and barbecue, hot pot is really healthy, because frying and roasting at high temperature will produce harmful substances such as acrylamide, a potential carcinogen. The World Health Organization has listed frying and high-temperature roasting as Class 2A carcinogens, especially foods rich in carbohydrates, which will produce acrylamide when cooked at a high temperature above 120°C, and are clear carcinogens.

In contrast, even the red oil hot pot, the upper floating layer of oil and the lower half of it are all kinds of broth, and the temperature at which the soup boils after heating is about 100℃. In this respect, hot pot is a healthier choice.

Eat a variety of ingredients at one meal

Balanced nutrition hot pot can do it.

According to the dietary guidelines of China residents, it is suggested that everyone should eat at least 12 kinds of food every day. Is it difficult? But a hot pot can simply complete this KPI!

No matter whether it is Chinese food or western food, almost no one can eat a variety of ingredients in one meal like hot pot. There are well-prepared meat, red meat and white meat, leafy vegetables and potatoes, fish and shrimp and internal organs. The variety of food is complete and diverse. From this point of view, the nutritional balance of hot pot is very good!

Does nitrite cause cancer?

There is indeed nitrite in the hot pot. The longer the hot pot is cooked, the higher the nitrite content in the soup. In the hot pot boiled for 90 minutes, nitritesaltContent reached5.2mg/L-15.73mg/L。 However, to achieve nitrite poisoning, it is necessary to ingest 200mg-500mg of nitrite, and reaching this level means drinking about 12.5L of hot pot soup.

Unless a large number of long-term intake of nitrite, lack of antioxidants, or accompanied by gastrointestinal diseases, it may be carcinogenic. Therefore, under normal circumstances, eating hot pot will not cause nitrite poisoning or even cancer.　

How much does hot pot eat to get bowel cancer?

Many people think that one of the reasons why hot pot is unhealthy is spicy. If you eat it often, your stomach can’t stand it, and even think that eating too much spicy hot pot will cause intestinal cancer.

But eating Chili peppers is not necessarily related to the occurrence of intestinal cancer. Therefore, it is unreasonable to think that hot pot is carcinogenic because it is spicy.

There are many reasons that can cause diarrhea after eating, such as stale ingredients, food poisoning caused by food safety problems, allergies to certain foods, and gastrointestinal diseases, etc., but it may be these common and related reasons.

Eat too spicy

Although we just said that pepper is not necessarily related to intestinal cancer, capsaicin in pepper may cause burning and tingling in the gastrointestinal tract of some people, and it will also accelerate the peristalsis of the gastrointestinal tract, leading to diarrhea.

Hotpot+cold drink

Many friends like to eat hot pot with iced coke and iced beer. Some people have nothing to eat and drink, but some people can’t stand it. In fact, it is the cold and hot diet that leads to abnormal contraction of gastrointestinal tract, indigestion and diarrhea.

Eat too long, too much

Eating for a long time will greatly increase the burden on the gastrointestinal tract. The mouth has been eating, and the secretion of digestive juices such as gastric juice, bile and pancreatic juice has not stopped. If this process lasts for several hours, the glands in the digestive tract can’t get normal rest, which may lead to gastrointestinal dysfunction and abdominal pain, diarrhea, etc., and may lead to chronic gastroenteritis, pancreatitis and other diseases.

Eating too hot can easily lead to esophageal cancer.

Too hot food directly into the mouth will not only damage the esophageal mucosa and burn our mouth, but also damage the gastrointestinal mucosa and increase the risk of esophageal cancer.

More oil and more salt.

According to the Dietary Guide for China Residents (2022), adults should not consume more than 5g of salt and 25-30g of cooking oil every day. In fact, China is a big consumer of salt and oil, with an average of 10.5g of salt and 42.1g of oil per day. Moreover, in order to be fragrant and delicious, the bottom of the hot pot is not only rich in oil, but also high in salt. Coupled with the blessing of sesame oil, salt, monosodium glutamate, oyster sauce and other ingredients in the oil dish, after eating a hot pot, the intake of oil and salt casually exceeds the standard.

High purine is easy to cause gout.

① When scalding hot pot, the purine in animal viscera is high.

For example, hairy belly, goose intestines, etc., eating a lot of animal viscera regularly is likely to cause hyperuricemia, so it is even worse for patients who already have hyperuricemia or even gout.

② The soup in the hot pot is high in purine.

Most of the broth in the white pot was originally made of chicken, bones, etc., and the purine content is already relatively high. However, when you put shrimp and meat in the hot pot, the longer you cook, the higher the purine content in the soup will continue to rise.

So how can we eat hot pot healthily?These points suggest Amway to everyone.

(Editor: Lu Ming)